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Enantioselective g-borylation of unsaturated
amides and stereoretentive Suzuki–Miyaura cross-
coupling†
Gia L. Hoang and James M. Takacs *
The rhodium-catalyzed, directed catalytic asymmetric hydroboration of g,d-unsaturated amides affords
a direct route to chiral acyclic secondary g-borylated carbonyl derivatives in high enantiomeric purity. In
contrast to a similar b-borylated amide derivative, the g-borylated amide undergoes Suzuki–Miyaura
cross-coupling with stereoretention. The utility of the boronic ester products is further illustrated by
other stereospecific C–B bond transformations leading to g-amino acid derivatives, 1,4-amino alcohols,
and 5-substituted-g-lactone and g-lactam ring systems.
Introduction
Chiral boronic esters are valuable synthetic intermediates for
a variety of stereospecic transformations.1–3 Consequently, an
assortment of enantioselective routes for their preparation are
under active development.4–19 We have focused on the rhodium-
catalyzed catalytic asymmetric hydroboration (CAHB) of b,g-
unsaturated amides,20 esters,20a and oxime ethers21 for the
preparation of functionalized chiral boronic esters. For
example, disubstituted alkenes such as (E)-1 undergo highly
enantioselective b-borylation by pinacolborane (pinBH) when
catalyzed by the combination of (R)-L1 with [Rh(nbd)2BF4] (i.e.,
2 : 1 L1 : Rh). CAHB followed by oxidation of the C–B bond
affords b-hydroxy amide (S)-2 in an enantiomeric ratio (er)
greater than 99 : 1 (Fig. 1).20e
In an effort to expand the scope of CAHB, g,d-unsaturated
amides such as 3 were explored.22 Such substrates differ from 1
in a number of important ways including, (i) the alkene is more
remote than in the b,g-unsaturated amides, (ii) substrate 3
contains two distinctly different alkene moieties, although each
is ostensibly positioned g,d- with respect to the carbonyl
directing group, and (iii) enantioselective borylation of the
endocyclic alkene requires controlling the stereochemical
course by desymmetrization rather than p-facial discrimina-
tion, a fundamentally different set of requirements.23 In the
event, substrate 3 undergoes CAHB/oxidation to give the
monounsaturated g-hydroxy amide (1S,3S)-4 in high yield
(80%), regioselectivity (>20 : 1) and enantioselectivity (99 : 1 er).
Only the endocyclic double bond in 3 undergoes reaction; the
pendant acyclic alkene is untouched. We now report the effi-
cient, regioselective g-borylation of a similarly disposed alkene
in g,d-unsaturated amide 5a (Fig. 1). CAHB by pinBH (0.5%
[Rh(nbd)2BF4/2 (R)-L1]) followed by oxidation affords chiral
g-hydroxy amide (S)-7a in 79% overall yield (97 : 3 er). While
conjugate addition11 and C–H activation10a methodologies
provide efficient alternatives to CAHB for enantioselective
b-borylation of carbonyl compounds, direct g-borylation is
unique to CAHB.
Fig. 1 CAHB/oxidation of b,g- versus g,d-unsaturated amides.
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Results and discussion
The g,d-unsaturated amides (E)-5b–n shown in Fig. 2, along
with several related structures, were treated with the catalyst
system for g-borylation (i.e., 2 : 1 combinations of L1 or L2 with
[Rh(nbd)2BF4], 0.5 mol% unless otherwise noted). In addition to
phenyl amide 5a described above, the corresponding Weinreb
amide 5b, the morpholine amide24 5c and benzyl amide 5d
undergo CAHB to afford the intermediate g-borylated amides
6b–d with high levels of enantioselectivity. Within this series of
amides, the secondary amides (i.e., N-phenyl and N-benzyl) give
the highest g-selectivity (>20 : 1). Oxidations of 6b–d afford the
corresponding chiral g-hydroxy amides 7b–d ($94 : 6 er).
CAHBs of 5c and 5d were carried out on gram scale giving chiral
boronic esters 6c (82%, 94.5 : 5.5) and 6d (81%, 96.5 : 3.5 er) in
good yield and without loss of enantioselectivity. CAHB/
oxidation of an isomeric (Z)-alkene, benzyl amide (Z)-5d,
affords results similar to those obtained with the (E)-isomer.
In contrast to amides 5a–d, the analogous ester 8 is largely
recovered unchanged upon attempted CAHB; only trace
amounts of borylated products are identied along with some
evidence for alkene isomerization. d,3-Unsaturated amide 9,
a one-carbon homologue of benzyl amide (E)-5d, is found to be
considerably less reactive and less selective. Complete
consumption of starting material requires 2% catalyst loading
to afford 56% yield of a mixture of borylated products.25
Benzyl amides 5e–g containing heteroaromatic ring systems
are nonetheless good substrates under the standard CAHB/
oxidation conditions yielding 7e–g, respectively. Certain
branched alkyl substituents (i.e., 5h–j) are also well tolerated. In
particular, the chiral substrate (E)-5j demonstrates that (i) the
proximal disubstituted alkene with respect to the amide
directing group undergoes CAHB while the more distal trisub-
stituted alkene is untouched and (ii) the stereochemical course
of g-borylation is efficiently catalyst controlled. CAHB/oxidation
with (R)-L2 affords (4S,7S)-7j; (S)-L2 affords (4R,7S)-7j. The silyl
ether moiety in 5k is tolerated and affords 7k (78%, 97 : 3 er).
Chiral acetal 5l again undergoes catalyst controlled g-borylation
with high diastereoselectivity; (R)-L1 affords (S,S)-7l (72%, 95 : 5
dr); (S)-L1 affords (R,S)-7l in the same yield and diastereomer
ratio. However, substrate 5m, in which the chiral acetal moiety
is in closer proximity to the site of hydroboration, shows
a strong matched/mismatched effect. While (R)-L1 affords (R,S)-
7m (70%, 92 : 8 dr), the catalyst employing (S)-L1 gives rise to
a complex mixture of regioisomers 10. Substrate 5n (R1 ¼ Me)
also exhibits only modest regioselectivity (3 : 1), perhaps due to
Fig. 2 Substrate scope for CAHB of g,d-unsaturated amides. aUnless otherwise noted all reaction use 0.5% [Rh(nbd)2BF4/2 (R)-L1], 1.5 equiv.
pinBH, THF, 40 C (12 h) followed by oxidation using H2O2/aq. NaOH. Unless otherwise noted, the isolated yield is that of the major regioisomer
and reflects the average of three experiments generally exhibiting a spread of 2%; regioselectivity is determined from the crude 1H NMR of 7.
Enantiomer ratios (er) are determined by chiral HPLC analysis; diastereomer ratios (dr) are determined for the purified mixture of diastereomers
by integratingmajor andminor 13C NMR resonances. b2.0% [Rh(nbd)2BF4/2 (R)-L1].
cOxidation conditions: NaBO3/H2O.
d1.0% [Rh(nbd)2BF4/2 L1];
(R)-L1 is used unless noted otherwise in the figure. e1.0% [Rh(nbd)2BF4/2 L2].
fer is determined by 19F NMR of the correspondingMosher ester (see
ESI for details†).
4512 | Chem. Sci., 2017, 8, 4511–4516 This journal is © The Royal Society of Chemistry 2017




























































































the size of the vinyl substituent compared to other derivatives
described above; however, CAHB proceeds in good yield and
high enantioselectivity (61%, 95 : 5 er).
Having developed an efficient method for the g-borylation of
g,d-unsaturated amides, Suzuki–Miyaura cross-coupling of 11
was examined (Fig. 3). Stereochemical aspects of the palladium-
catalyzed cross-coupling of chiral secondary organoboron
derivatives have recently attracted a great deal attention.
Molander,26 Suginome,27 and Hall28 reported that b-borylated
carbonyl derivatives 12–14, whether as the boronic ester or the
triuoroborate salt, undergo cross-coupling with stereo-
inversion. The stereochemical course is rationalized by intra-
molecular coordination between the carbonyl oxygen and the
boron atom of the boronic ester or the partially hydrolyzed tri-
uoroborate. The intramolecular coordination promotes
invertive transmetallation resulting in overall stereoinversion
for cross-coupling. Biscoe19a,29 also found stereoinversion for
simple substrates lacking functionality needed for coordination
to boron during the course of transmetallation (e.g., 15). On the
other hand, Suginome30 reported that boracyclic intermediate
16 undergoes cross-coupling with stereoretention. Similarly,
Morken31 reported that 17 undergoes hydroxyl-directed, inner-
sphere, retentive transmetallation and overall cross-coupling
with stereoretention. However, when the hydroxyl is one-
carbon further removed, 18 fails to undergo cross-coupling
under the otherwise same conditions. We have previously
shown that 19 undergoes cross-coupling with overall
stereoretention.22
Chiral boronic ester 6c (i.e., the morpholine amide) was
converted to its corresponding triuoroborate salt 11c32 and
subjected to palladium-catalyzed cross-coupling using the
Buchwald cataCXium® A Pd G3 (20) precatalyst.22,33 Cross-
coupling with chlorobenzene yields amide (S)-21c (63%); 4-
chloroanisole yields (S)-22c (52%). The products are obtained
with essentially complete overall stereoretention.34 We nd that
the nature of the amide is important to the success of the cross-
coupling. In contrast to the tertiary morpholine amide, the
analogous secondary amide 11d does not undergo cross-
coupling under the conditions employed for 11c. Hall et al.28a
reported that b-boronic esters of secondary amides failed to
cross-couple in cases where the corresponding tertiary amide
coupled smoothly.
Chiral organoboronates are useful for a variety of other
stereospecic transformations. Fig. 4 illustrates several exam-
ples starting from chiral boronic esters 6b–d; the latter are
isolated in 69–82% yield from the corresponding alkenes.
Treating 6b with H2O2/aq. NaOH affords the known chiral 5-
substituted-g-lactone 23 (95%).35 As an alternative to palladium-
catalyzed cross-coupling, the morpholine amide derivative 6c
undergoes stereoretentive cross-coupling with 2-lithiothiofuran
under the conditions developed by Aggarwal2e to give 24c (84%).
Compound 6c also undergoes BCl3-assisted amination with
benzyl azide under the conditions reported by Knochel36 to form
the g-amino acid derivative 25c (65%). Phenyl azide also serves
as a good nucleophile in such amination reactions, and 6c is
converted to the corresponding N-phenyl g-amino acid en route
to the 5-substituted-g-lactam 26 (68%) by acid catalyzed cycli-
zation. Benzyl amide derivative 6d is efficiently converted to 1,4-
aminoalcohol 27d aer oxidation of the C–B bond followed by
amide reduction with LAH (94%). While the secondary N-benzyl
amide 11d failed in the attempted palladium-catalyzed cross-
coupling described above, 6d undergoes efficient vinylation in
a sequence initiated the by treatment with excess vinyl
Grignard;2h amide 28d is formed in high yield (93%).
Conclusions
g,d-Unsaturated secondary (i.e., N-phenyl and N-benzyl) and
tertiary (i.e., Weinreb and morpholine) amides undergo effi-
cient rhodium-catalyzed CAHB to afford g-borylated derivatives
in good yield and with high levels of asymmetric induction;
enantioselectivity as high as 97 : 3 er is observed. While two
Fig. 3 Stereochemical course of Suzuki–Miyaura cross-coupling with
chiral secondary boronic esters or trifluoroborate salts.
Fig. 4 Stereospecific transformations of organoboranes 6b–d.
Conditions: (a) NaOH/H2O2; (b) (i) n-BuLi, thiophene, (ii) NBS; (c) BCl3,
BnN3; (d) BCl3, PhN3; (e) 6 M HCl; (f) LiAlH4; (g) (i) vinylMgBr, (ii) I2/
NaOMe.
This journal is © The Royal Society of Chemistry 2017 Chem. Sci., 2017, 8, 4511–4516 | 4513




























































































good alternative methods are available to prepare chiral
secondary b-borylated carbonyl compounds, the present
method of directed-CAHB provides to our knowledge the rst
direct route to chiral acyclic secondary g-borylated carbonyl
compounds with high regio- and enantioselectivity.
A previous study found b- and g-borylation of related
substrates differ in the sense of stereoinduction, i.e., p-facial
discrimination.20a However, it is not the case in the present
study; b-borylation of b,g-unsaturated amide 1 and g-borylation
of the one-carbon homologue g,d-unsaturated amide 5 add to
the same face of the alkene. In the present study, CAHB of
a substrate bearing both di- and trisubstituted alkene moieties
(i.e., 5j) occurs only on the disubstituted double bond proximal
to the carbonyl group. Chiral substrates 5j and 5l undergo
highly diastereoselective CAHB with catalyst control; however,
substrate 5m, in which the resident oxygen-bearing stereocenter
resides adjacent to the alkene, exhibits a strong matched and
mismatched effect with enantiomeric catalysts.
The g-borylated products are found to undergo stereo-
retentive palladium-catalyzed Suzuki–Miyaura cross-coupling,
presumably via amide-directed inner-sphere stereoretentive
transmetallation, as well as stereoretentive C–B to C–C trans-
formations using main group organometallic reagents (e.g.,
lithium and magnesium). In addition, a variety of other
stereospecic transformations are highlighted by the conver-
sions of chiral, secondary g-boronic esters 6b–d to 1,4-amino
alcohols, g-amino acid derivatives, and 5-substituted-g-lactone
and g-lactam ring systems. Further studies are in progress.
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General procedures. Reactions were carried out in a dry nitrogen atmosphere. Tetrahydrofuran 
(THF) was freshly distilled under sodium metal and benzophenone. HPLC solvents were filtered 
through Millipore filter paper. 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (pinBH) was distilled 
immediately before use. All synthesized compounds were purified with flash chromatography 
using EMD Silica Gel 60 Geduran®, distilled via short path distillation, or triturated. Thin Layer 
Chromatography analyses were performed on Analtech Silica Gel HLF (0.25 mm) precoated 
analytical plates and visualized with use of handheld short wavelength UV light, Iodine stain (I2 
and EMD Silica Gel 60 Geduran®) and Vanillin stain (Ethanol, H2SO4, and vanillin). HPLC 
analyses were performed with use of an ISCO model 2360 HPLC and Chiral Technologies, Inc. 
chiral HPLC columns (Chiralcel-OJ-H, column: 250 x 4.6 mm; Chiralcel-OD, column: 250 x 4.6 
mm; Chiralpak-IC, column: 250 x 4.6 mm; (S,S)-WHELK-O 1, column: 250 x 4.6 mm) and 
monitored with UV-VIS detector (Shimadzu SPD-10AVP/10AVP, λ = 210 nm). Data were recorded 
and analyzed with ChromPerfect chromatography software (version 5.1.0). NMR spectra were 
recorded on 400 MHz and 300 MHz Bruker Advance NMR spectrometers using residue CHCl3 (δ 
7.27 ppm) or CDCl3 (δ 77.0 ppm) for reference unless otherwise specified. Peaks are expressed as 
m (unresolved multiplet), q (quartet), t (triplet), d (doublet) or s (singlet). IR spectra were recorded 
using an Avatar 360 FT-IR. Optical rotations were measured as solutions, 1.0 g/100 mL in 
chloroform or methanol unless indicated otherwise, and recorded using an Autopol III automatic 
polarimeter. HRMS analyses were performed by the Nebraska Center for Mass Spectrometry. 






 B1 (pinBH) B2 (tmdBH) B3 (catBH) 
Ligand Entry 5d 7d % ee Entry 5d 7d % ee Entry 5d 7d % ee
L1 1 0 91 93 14 80 12 n.d. 27 0 81 37 
L2 2 0 95 90 15 60 15 n.d. 28 0 83 30 
L3 3 0 64 87 16 35 0 n.d. 29 – 
L4 4 0 52 85 17 27 5 n.d. 30 – 
L5 5 0 19 85 18 11 0 n.d. 31 – 
L6 6 0 90 90 19 70 10 n.d. 32 – 
L7 7 80 0 n.d. 20 >90 0 n.d. 33 0 60 n.d. 
L8 8 84 0 n.d. 21 >90 0 n.d. 34 30 57 n.d. 
L9 9 0 70 –43b 22 >90 0 n.d. 35 18 69 –8b
L10 10 0 85 46 23 >90 0 n.d. 36 10 76 48 
L11 11 0 14 n.d. 24 >90 0 n.d. 37 0 40 n.d. 
L12 12 50 17 n.d. 25 80 11 n.d. 38 22 67 –16c
L13 13 0 24 n.d. 26 75 0 n.d. 39 6 36 n.d. 
a CAHB conditions: 0.0528 mmol 5d, 1.0 mol% Rh(nbd)2BF4, 1.0 mol% bidentate ligand or 2.0 mol% monodentate 
ligand, 1.5 equiv. borane, THF (C = 0.106 M), 40 oC, 5h; yield was reported as crude 1H NMR yield using mesitylene 
as an internal standard and an average of two experiments generally exhibiting a spread of ±2%; %ee was determined 
by chiral HPLC Chiralpak-IC column (HPLC conditions vide infra); n.d. = not determined. b Enantioswithching 
observed when using (R)-L9. c (S)-L12 was used. 




Entry Pd source Ligand Base Y  22c (%) 22d (%)
1 Pd(OAc)2 XPhos K2CO3 Cl 0 0 
2 Pd2(dba)3 XPhos K2CO3 Cl 38 0
3 Pd2(dba)3 P(tBu)3.HBF4 K2CO3 Cl 10 0
4 Pd2(dba)3 cataCXium® A K2CO3 Cl 15 0
5 XPhos Pd G3 – K2CO3 Cl 21 0
6 cataCXium® A Pd G2 – K2CO3 Cl 49 0
7 cataCXium® A Pd G3 – K2CO3 Cl 52 0
8a cataCXium® A Pd G3 cataCXium® A K2CO3 Cl 45 0
9 cataCXium® A Pd G3 – Cs2CO3 Cl 50 0
10 cataCXium® A Pd G3 – K3PO4 Cl 47 0
11 cataCXium® A Pd G3 – CsOH Cl 0 0
12 cataCXium® A Pd G3 – K2CO3 Br 45 0
13 cataCXium® A Pd G3 – Cs2CO3 Br 42 0
14b cataCXium® A Pd G3 – K2CO3 Cl 48 0
15c cataCXium® A Pd G3 – K2CO3 Cl 0 0
16c cataCXium® A Pd G3 – Cs2CO3 Cl 0 0
General conditions: 7.5 mol% Pd-precatalyst or 10 mol% Pd(OAc)2 or 5 mol% Pd2(dba)3; 20 mol% ligand; isolated 
yield. a  Additional 7.5 mol% cataCXium® A. b Toluene:H2O = 0.25:0.25 mL. c Bpin is used instead of BF3Cs. 





General procedure for the preparation of (E)--unsaturated amides via 
trimethylaluminum mediated amide bond formation (GP1) 
 
Prepration of (E)-7-phenyl-4-heptenecarboxylic acid phenyl amide ((E)-5a). To  a 
solution of aniline (2 equiv, 10 mmol, 0.91 mL) in DCM (20 mL) was slowly added 
trimethylaluminum (1.62 equiv, 2.0 M in hexanes, 8.1 mmol, 4.05 mL) at room temperature. The 
resulting mixture was stirred at room temp for 30 mins, and the corresponding ethyl ester ((E)-7-
phenyl-4-heptenecarboxylic acid ethyl ester (E)-8, 5 mmol, 1.16g) was added dropwise. The 
resultant mixture was heated overnight at 35 oC. After cooling to room temperature, the reaction 
mixture was quenched with HCl (1M) and extracted with DCM (3 x 20 mL). The combined organic 
extracts were dried (anhyd. Na2SO4) and concentrated under reduced pressure. Flash 
chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate) affords the title compound (992 
mg, 71%) as a white solid: m.p. 106.0–107.0 oC; TLC analysis Rf  0.65 (60:40 hexanes:ethyl 
acetate); 1H NMR (400 MHz, CDCl3) δ 7.54 (2H, d, J = 7.8 Hz, m,m’), 7.48 (1H, br s, NH), 7.25–
7.40 (4H, m, b,b’,n,n’), 7.15–7.25 (3H, m, c,c’,a), 7.13 (1H, t, J = 7.4 Hz, o), 5.40–5.70 (2H, m, 
g,h), 2.70 (2H, t, J = 7.4 Hz, e), 2.25–2.50 (6H, m, f,i,j); 13C NMR (100 MHz, CDCl3) δ 171.03 
(k), 142.00 (d), 138.06 (l), 131.30 (h), 129.10 (g), 129.05 (n,n’), 128.61 (b,b’), 128.40 (o), 125.92 
(c,c’), 124.36 (a), 120.07 (m,m’), 37.65 (e), 36.01 (j), 34.44 (f), 28.60 (i); IR (neat) 3305 (N-H 
stretch), 3265, 2193, 1664 (C=O stretch), 1603, 1546, 1439, 972, 757, 693 cm-1; HRMS (ESI) 
calcd. for C19H21NNaO (M+Na): 302.1521, found 302.1531 m/z. 
 
(E)-7-phenyl-4-heptenecarboxylic acid Weinreb amide (5b). Following GP1 with N-
methoxy-N-methylamine hydrochloride (5 equiv, 25 mmol, 2.4 g) and trimethylaluminum (5 
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equiv, 2.0 M in hexanes, 25 mmol, 12.5 mL)  affords, after flash chromatography on silica gel 
(80:20-60:40 hexanes:ethyl acetate), the title compound (780 mg, 63%) as a yellow oil; TLC 
analysis Rf  0.5 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (2H, m, 
b,b’), 7.15–7.25 (3H, m, a,c,c’), 5.45–5.65 (2H, m, g,h), 3.69 (3H, s, m), 3.20 (3H, s, l),  2.69 (2H, 
t, J = 7.4 Hz, e), 2.49 (2H, m, j), 2.20–2.40 (4H, m, f,i); 13C NMR (100 MHz, CDCl3) δ 174.14 
(k), 142.16 (d), 130.50 (h), 129.63 (g), 128.59 (b,b’), 128.35 (c,c’), 125.84 (a), 61.33 (m), 36.10 
(e), 34.50 (f), 32.30 (l), 32.01 (j), 27.65 (i) ; IR (neat) 2934 (C-H sp3 stretch), 1661 (C=O stretch), 
1452, 1413, 1383 (C-N stretch), 969, 698 cm-1; HRMS (ESI) calcd. for C15H21NNaO2 (M+Na): 
270.1470, found 270.1469 m/z. 
 
(E)-7-phenyl-4-heptenecarboxylic acid morpholino amide (5c). Following GP1 with 
morpholine (2 equiv, 10 mmol, 0.87 mL) affords, after flash chromatography on silica gel (70:30-
50:50 hexanes:ethyl acetate), the title compound (1.03 g, 75%) as a yellow oil; TLC analysis Rf  
0.4 (40:60 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (2H, m, b,b’), 7.15–
7.25 (3H, m, a,c,c’), 5.40–5.60 (2H, m, g,h), 3.55–3.70 (6H, m, l,l’,m,m’), 3.35–3.50 (2H, m, l,l’),  
2.68 (2H, t, J = 7.5 Hz, e), 2.20–2.40 (6H, m, f,i,j); 13C NMR (100 MHz, CDCl3) δ 171.23 (k), 
142.05 (d), 131.68 (h), 129.47 (g), 128.59 (b,b’), 128.36 (c,c’), 125.87 (a), 67.05 and 66.76 (m,m’), 
46.08 and 42.01 (l,l’), 36.04 (e), 34.46 (f), 33.13 (j), 28.28 (i); IR (neat) 2914 (C-H sp3 stretch), 
2852, 1642 (C=O stretch), 1428, 1113, 968, 699 cm-1; HRMS (ESI) calcd. for C17H23NNaO2 
(M+Na): 296.1626, found 296.1628 m/z. 
 
(E)-7-phenyl-4-heptenecarboxylic acid benzyl amide ((E)-5e). Following GP1 with 
benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on silica gel (80:20-
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60:40 hexanes:ethyl acetate), the title compound (1.15 g, 78%) as a white solid: m.p. 65.5–66.5 
oC; TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.15–7.40 
(10H, m, a,b,b’,c,c’,n,n’,o,o’,p), 5.89 (1H, br s, NH), 5.40–5.60 (2H, m, g,h), 4.44 (2H, d, J = 5.7 
Hz, l), 2.67 (2H, t, J = 7.3 Hz, e), 2.20–2.40 (6H, m, f,i,j); 13C NMR (100 MHz, CDCl3) δ 172.45 
(k), 142.04 (d), 138.55 (m), 131.03 (h), 129.23 (g), 128.80 (b,b’), 128.61 (o,o’), 128.38 (c,c’), 
127.93 (n,n’), 127.60 (p), 125.89 (a), 43.66 (l), 36.71 (j), 35.96 (e), 34.40 (f), 28.73 (i); IR (neat) 
3285 (N-H stretch), 3028, 2915, 1635 (C=O stretch), 1537 (N-H bend), 1452, 1220, 965, 740, 694 
cm-1; HRMS (ESI) calcd. for C20H23NNaO (M+Na): 316.1677, found 316.1681 m/z. 
 
(Z)-7-phenyl-4-heptenecarboxylic acid benzyl amide ((Z)-5d). Following GP1 with (Z)-
8 (5 mmol, 1.16g), benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography 
on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound (1.08 g, 73%) as a light 
yellow oil; TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.15–
7.40 (10H, m, a,b,b’,c,c’,n,n’,o,o’,p), 6.03 (1H, br s, NH), 5.45–5.55 (1H, m, h), 5.35–5.45 (1H, 
m, g), 4.41 (2H, d, J = 5.7 Hz, l), 2.69 (2H, t, J = 7.8 Hz, e), 2.41 (2H, q, J = 7.4 Hz, f), 2.33 (2H, 
q, J = 7.4 Hz, i), 2.08 (2H, t, J = 8.6 Hz, j); 13C NMR (100 MHz, CDCl3) δ 172.53 (k), 142.10 (d), 
138.55 (m), 130.29 (h), 128.81 (b,b’), 128.78 (o,o’), 128.41 (g,c,c’), 127.92 (n,n’), 127.57 (p), 
125.92 (a), 43.65 (l), 36.53 (j), 35.91 (e), 29.29 (f), 23.61 (i); IR (neat) 3285 (N-H stretch), 3026, 
2922, 1642 (C=O stretch), 1543 (N-H bend), 1495, 1453, 728, 695 cm-1; HRMS (ESI) calcd. for 




(E)-7-(furan-2-yl)-4-heptenecarboxylic acid benzyl amide (5e).a Following GP1 with 
the corresponding ethyl ester ((E)-7-(furan-2-yl)-4-heptenecarboxylic acid ethyl ester, 5 mmol, 1.1 
g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on silica gel 
(80:20-60:40 hexanes:ethyl acetate), the title compound (596 mg, 42%) as a white solid: m.p. 60.5–
61.5 oC; TLC analysis Rf  0.35 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.25–
7.40 (6H, m, a,b,b’,c,c’,p), 6.28 (1H, dd, J = 3.0 Hz, 1.9 Hz, o), 5.98 (1H, dd, J = 3.1 Hz, 0.6 Hz, 
n), 5.90 (1H, br s, NH), 5.40–5.60 (2H, m, i,j), 4.44 (2H, d, J = 5.7 Hz, e), 2.67 (2H, t, J = 7.4 Hz, 
l), 2.20–2.40 (6H, m, g,h,k); 13C NMR (100 MHz, CDCl3) δ 172.40 (f), 155.78 (m), 140.89 (p), 
138.51 (d), 130.53 (i), 129.50 (j), 128.80 (b,b’), 127.92 (c,c’), 127.60 (a), 110.17 (o), 105.03 (n), 
43.66 (e), 36.64 (g), 31.02 (k), 28.68 (h), 28.07 (l); IR (neat) 3293 (N-H stretch), 2916, 1632 (C=O 
stretch), 1538 (N-H bend), 1506, 1453, 729, 695 cm-1; HRMS (ESI) calcd. for C18H21NNaO2 
(M+Na): 306.1470, found 306.1477 m/z. 
 
(E)-7-(thiophen-2-yl)-4-heptenecarboxylic acid benzyl amide (5f).b Following GP1 
with the corresponding ethyl ester ((E)-7-(thiophen-2-yl)-4-heptenecarboxylic acid ethyl ester, 5 
mmol, 1.19g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography 
on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound (945 mg, 63%) as a white 
solid: m.p. 62.0–63.0 oC; TLC analysis Rf  0.35 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, 
CDCl3) δ 7.30–7.40 (2H, m, b,b’), 7.25–7.30 (3H, m, a, c,c’), 7.12 (1H, dd, J = 5.2 Hz, 0.8 Hz, p), 
6.93 (1H, dd, J = 4.9 Hz, 3.5 Hz, o), 6.79 (1H, d, J = 2.6 Hz, n), 6.20 (1H, br s, NH), 5.40–5.60 
(2H, m, i,j), 4.42 (2H, d, J = 5.7 Hz, e), 2.87 (2H, t, J = 7.4 Hz, l), 2.30–2.40 (4H, m, h,k), 2.26 
(2H, t, J = 7.1 Hz, g); 13C NMR (100 MHz, CDCl3) δ 172.55 (f), 144.86 (m), 138.62 (d), 130.32 
(i), 129.85 (j), 128.78 (b,b’), 127.89 (c,c’), 127.56 (a), 126.81 (o), 124.34 (p), 123.10 (n), 43.61 
(e), 36.56 (g), 34.65 (k), 30.00 (h), 28.75 (l); IR (neat) 3291 (N-H stretch), 3030, 2915, 1629 (C=O 
                                                            
a The substrate should be used immediately after preparation or stored inside a glovebox to maintain its original quality 
b The substrate should be used immediately after preparation or stored inside a glovebox to maintain its original quality 
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stretch), 1531 (N-H bend), 1453, 968, 746, 693 cm-1; HRMS (ESI) calcd. for C18H21NNaOS 





HN f g h i











(E)-7-(2,5-dimethyl-1H-pyrrol-1-yl)-4-heptenecarboxylic acid benzyl amide (5g).c 
Following GP1 with the corresponding ethyl ester ((E)-7-(2,5-dimethyl-1H-pyrrol-1-yl)-4-
heptenecarboxylic acid ethyl ester, 5 mmol, 1.25g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) 
affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title 
compound (840 mg, 54%) as a colorless oil; TLC analysis Rf  0.5 (40:60 hexanes:ethyl acetate); 
1H NMR (400 MHz, CDCl3) δ 7.35–7.40 (2H, m, b,b’), 7.25–7.35 (3H, m, a,c,c’), 5.99 (1H, br s, 
NH), 5.77 (2H, s, o,o’), 5.40–5.50 (2H, m, i,j), 4.44 (2H, d, J = 5.8 Hz, e), 3.76 (2H, t, J = 7.4 Hz, 
l),  2.35–2.45 (2H, m, h), 2.25–2.35 (2H, m, k), 2.25 (2H, t, J = 7.0 Hz, g, overlapping with n,n’), 
2.23 (6H, s, n,n’); 13C NMR (100 MHz, CDCl3) δ 172.35 (f), 138.63 (d), 131.62 (i), 128.79 
(b,b’,m,m’), 127.92 (c,c’), 127.58 (a), 127.40 (j), 105.12 (o,o’), 43.63 (e), 43.48 (l), 36.51 (g), 
34.18 (k), 28.80 (h), 12.73 (n,n’); IR (neat) 3283 (N-H stretch), 2914, 1643 (C=O stretch), 1539 
(N-H bend), 1453, 1407, 970, 743, 697 cm-1; HRMS (ESI) calcd. for C20H26N2NaO (M+Na): 
333.1943, found 333.1950 m/z. 
 
(E)-6-methyl-4-heptenecarboxylic acid benzyl amide (5h). Following GP1 with the 
corresponding ethyl ester ((E)-6-methyl-4-heptenecarboxylic acid ethyl ester, 5 mmol, 0.85 g) and 
benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on silica gel (80:20-
60:40 hexanes:ethyl acetate), the title compound (751 mg, 65%) as a white solid: m.p. 45.0–45.5 
oC; TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.15–7.40 
(5H, m, a,b,b’,c,c’), 6.08 (1H, br s, NH), 5.30–5.50 (2H, m, i,j), 4.42 (2H, d, J = 5.7 Hz, e), 2.15–
                                                            
c The substrate should be used immediately after preparation or stored inside a glovebox to maintain its original quality 
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2.40 (5H, m, g,h,k), 0.95 (6H, d, J = 6.7 Hz, l,l’); 13C NMR (100 MHz, CDCl3) δ 172.61 (f), 139.20 
(d), 138.55 (j), 128.76 (b,b’), 127.88 (c,c’), 127.53 (i), 125.35 (a), 43.61 (e), 36.73 (g), 31.04 (k), 
28.69 (h), 22.60 (l,l’); IR (neat) 3292 (N-H stretch), 2959, 2928, 2870, 1633 (C=O stretch), 1534 
(N-H bend), 1454, 1407, 968, 746, 694 cm-1; HRMS (ESI) calcd. for C15H21NNaO (M+Na): 
254.1521, found 254.1526 m/z. 
 
(E)-7-methyl-4-octenecarboxylic acid benzyl amide (5i). Following GP1 with the 
corresponding ethyl ester ((E)-7-methyl-4-octenecarboxylic acid ethyl ester, 5 mmol, 0.92 g) and 
benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash chromatography on silica gel (80:20-
60:40 hexanes:ethyl acetate), the title compound (873 mg, 71%) as a white semi-solid; TLC 
analysis Rf  0.4 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.30–7.40 (2H, m, 
b,b’), 7.20–7.30 (3H, m, a,c,c’),  6.09 (1H, br s, NH), 5.35–5.55 (2H, m, i,j), 4.42 (2H, d, J = 5.6 
Hz, e), 2.30–2.40 (2H, m, h), 2.25–2.30 (2H, m, g) 1.87 (2H, t, J = 6.6 Hz, k), 1.50–1.65 (1H, m, 
l), 0.87 (6H, d, J = 6.6 Hz, m,m’) ; 13C NMR (100 MHz, CDCl3) δ 172.57 (f), 138.55 (d), 130.78 
(i), 129.52 (j), 128.76 (b,b’), 127.89 (c,c’), 127.53 (a), 43.63 (e), 42.00 (k), 36.75 (g), 28.79 (h), 
28.45 (l), 22.37 (m,m’); IR (neat) 3286 (N-H stretch), 2953, 2923, 2868, 1642 (C=O stretch), 1544 
(N-H bend), 1454, 967, 696 cm-1; HRMS (ESI) calcd. for C16H23NNaO (M+Na): 268.1677, found 
268.1689 m/z. 
 
(S,E)-7,11-dimethyl-4,10-dodecadienecarboxylic acid benzyl amide (5j). Following 
GP1 with the corresponding ethyl ester ((S,E)-7,11-dimethyl-4,10-dodecadienecarboxylic acid 
ethyl ester, 5 mmol, 1.26 g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash 
chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound (1.14 g, 
73%) as a colorless oil; TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate); [α]D20 = +6.2o (c 2.0, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.22 
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(1H, br s, NH), 5.35–5.50 (2H, m, i,j), 5.11 (1H, tt, J = 7.2 Hz, 1.3 Hz, p),  4.40 (2H, d, J = 5.8 Hz, 
e), 2.30–2.40 (2H, m, h), 2.25–2.30 (2H, m, g), 1.90–2.05 (3H, m, k,o), 1.75–1.85 (1H, m, k), 1.70 
(3H, s, r), 1.62 (3H, s, s),1.40–1.50 (1H, m, l), 1.25–1.40 (1H, m, n), 1.10–1.20 (1H, m, n), 0.86 
(3H, d, J = 6.6 Hz, m); 13C NMR (100 MHz, CDCl3) δ 172.62 (f), 138.58 (d), 131.17 (q), 130.47 
(i), 129.69 (j), 128.73 (b,b’), 127.86 (c,c’), 127.49 (a), 124.98 (p), 43.60 (e), 40.05 (k), 36.77 (n), 
36.71 (g), 32.77 (l), 28.83 (h), 25.85 (r), 25.70 (o), 19.46 (m), 17.77 (s); IR (neat) 3277 (N-H 
stretch), 2959, 2911, 1643 (C=O stretch), 1545 (N-H bend), 1453, 968, 696 cm-1; HRMS (ESI) 
calcd. for C21H31NNaO (M+Na): 336.2303, found 336.2316 m/z. 
 
(E)-7-((triisopropylsilyl)oxy)-4-heptenecarboxylic acid benzyl amide (5k). Following 
GP1 with the corresponding ethyl ester ((E)-7-((triisopropylsilyl)oxy)-4-heptenecarboxylic acid 
ethyl ester, 5 mmol, 1.64 g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) affords, after flash 
chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate), the title compound (1.46 g, 
75%) as a colorless oil; TLC analysis Rf  0.5 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, 
CDCl3) δ 7.20–7.40 (5H, m, a,b,b’,c,c’), 6.14 (1H, br s, NH), 5.40–5.55 (2H, m, i,j), 4.41 (2H, d, 
J = 5.7 Hz, e), 3.67 (2H, t, J = 6.8 Hz, l), 2.20–2.40 (6H, m, g,h,k), 1.00–1.15 (21H, m, 
m,m’,m’’,n,n’,n’’); 13C NMR (100 MHz, CDCl3) δ 172.55 (f), 138.55 (d), 130.49 (i), 128.75 (b,b’), 
128.29 (j), 127.84 (c,c’), 127.51 (a), 63.44 (l), 43.61 (e), 36.52 (k), 36.50 (g), 28.85 (h), 18.14 
(n,n’,n’’), 12.11 (m,m’,m’’); IR (neat) 3283 (N-H stretch), 2942, 2864, 1644 (C=O stretch), 1545 
(N-H bend), 1455, 1100, 881, 679 cm-1; HRMS (ESI) calcd. for C23H39NNaO2Si (M+Na): 
412.2648, found 412.2652 m/z. 
 
(S,E)-6-(2,2-dimethyl-1,3-dioxolan-4-yl)-4-hexenecarboxylic acid benzyl amide (5l). 
Following GP1 with the corresponding ethyl ester ((S,E)-6-(2,2-dimethyl-1,3-dioxolan-4-yl)-4-
hexenecarboxylic acid ethyl ester, 5 mmol, 1.2 g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) 
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affords, after flash chromatography on silica gel (60:40-30:70 hexanes:ethyl acetate), the title 
compound (1.05 g, 69%) as a white semi-solid; TLC analysis Rf  0.25 (60:40 hexanes:ethyl 
acetate); [α]D20 = +19.2o (c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 
7.20–7.30 (3H, m, a,c,c’), 6.11 (1H, br s, NH), 5.40–5.60 (2H, m, i,j), 4.40 (2H, d, J = 5.7 Hz, e), 
4.00–4.10 (1H, m, l),  3.97 (1H, dd, J = 8.0 Hz, 6.0 Hz, m), 3.52 (1H, dd, J = 7.9 Hz, 7.0 Hz, m), 
2.30–2.40 (3H, m, h,k), 2.25–2.30 (2H, m, g), 2.15–2.25 (1H, m, k), 1.40 (3H, s, o), 1.33 (3H, s, 
o’); 13C NMR (100 MHz, CDCl3) δ 172.32 (f), 138.53 (d), 131.82 (i), 128.76 (b,b’), 127.86 (c,c’), 
127.54 (a), 126.52 (j), 109.00 (n), 75.53 (l), 68.92 (m), 43.60 (e), 36.92 (k), 36.37 (g), 28.70 (h), 
27.01 and 25.74 (o,o’); IR (neat) 3291 (N-H stretch), 2984, 2933, 1643 (C=O stretch), 1541 (N-H 
bend), 1454, 1369, 1213, 1154, 1058, 969, 697 cm-1; HRMS (ESI) calcd. for C18H25NNaO3 
(M+Na): 236.1732, found 326.1739 m/z. 
 
(S,E)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4-pentenecarboxylic acid benzyl amide (5m). 
Following GP1 with the corresponding ethyl ester ((S,E)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4-
pentenecarboxylic acid ethyl ester, 5 mmol, 1.14 g) and benzyl amine (2 equiv, 10 mmol, 1.1 mL) 
affords, after flash chromatography on silica gel (60:40-30:70 hexanes:ethyl acetate), the title 
compound (913 mg, 63%) as a colorless oil; TLC analysis Rf  0.25 (60:40 hexanes:ethyl acetate); 
[α]D20 = +25.1o (c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 
(3H, m, a,c,c’), 6.02 (1H, br s, NH), 5.79 (1H, td, J = 15.3 Hz, 6.5 Hz, i), 5.49 (1H, dd, J = 15.4 
Hz, 7.7 Hz, j), 4.35–4.50 (1H, m, k), 4.41 (2H, d, J = 5.7 Hz, e), 4.03 (1H, dd, J = 8.1 Hz, 6.1 Hz, 
l), 3.52 (1H, dd, J = 8.0 Hz, 8.0 Hz, l),  2.35–2.45 (2H, m, h), 2.25–2.35 (2H, m, g), 1.41 (3H, s, 
n), 1.38 (3H, s, n’); 13C NMR (100 MHz, CDCl3) δ 171.96 (f), 138.41 (d), 133.72 (i), 128.80 (b,b’), 
128.77 (j), 127.91 (c,c’), 127.62 (a), 109.25 (m), 69.48 (k), 43.68 (e), 35.84 (g), 28.23 (h), 26.83 
and 26.01 (n,n’); IR (neat) 3294 (N-H stretch), 2985, 2933, 2872, 1644 (C=O stretch), 1541 (N-H 
bend), 1454, 1369, 1244, 1213, 1155, 1057, 1028, 967, 859, 732, 697 cm-1; HRMS (ESI) calcd. 




(E)-4-hexenecarboxylic acid benzyl amide (5n). Following GP1 with the corresponding 
ethyl ester ((E)-4-hexenecarboxylic acid ethyl ester, 5 mmol, 712 mg) and benzyl amine (2 equiv, 
10 mmol, 1.1 mL) affords, after flash chromatography on silica gel (80:20-60:40 hexanes:ethyl 
acetate), the title compound (691 mg, 68%) as a white solid: m.p 58.5–59.5 oC; TLC analysis Rf  
0.4 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.20–
7.30 (3H, m, a,c,c’), 6.20 (1H, br s, NH), 5.25–5.55 (2H, m, i,j), 2.30–2.35 (2H, m, h), 2.20–2.30 
(2H, m, g), 1.64 (3H, d, J = 5.8 Hz, k); 13C NMR (100 MHz, CDCl3) δ 172.64 (f), 138.59 (d), 
129.64 (i), 128.74 (b,b’), 127.85 (c,c’), 127.49 (a), 126.43 (j), 43.58 (e), 36.60 (g), 28.75 (h), 18.00 
(k); IR (neat) 3289 (N-H stretch), 2918, 1633 (C=O stretch), 1548 (N-H bend), 1493, 1452, 1234, 
964, 747, 697 cm-1; HRMS (ESI) calcd. for C13H17NNaO (M+Na): 226.1208, found 226.1208 m/z. 




 To a cooled (0 oC) solution of (E)-6-phenylhex-3-enoic acid2 S2 (13.3 mmol, 2.53 g) in 
THF (50 mL) was added lithium aluminum hydride (LAH, 1.05 equiv, 14.0 mmol, 530 mg). The 
resulting mixture was warmed to room temperature and stirred overnight. The reaction mixture 
was quenched with 5N KOH (1 mL) and water (0.5 mL). Following by 30-min stir, the resultant 
mixture was filtered through a pad of celite and wash with ethyl acetate (2 x 5 mL). The filtrate 
was dried (anhyd. Na2SO4) and concentrated under reduced pressure to give the crude yellow oil 
S3 in quantitative yield which was used in the next step without further purification. 
 To a cooled (0 oC) solution of (E)-6-phenylhex-3-en-1-ol S3 (13.1 mmol, 2.31 g) in diethyl 
ether (20 mL) was added PBr3 (0.5 equiv, 6.6 mmol, 0.62 mL) dropwise. The resultant mixture 
was slowly warmed to room temperature and stirred overnight. The reaction mixture was quenched 
with brine solution (20 mL). The organic layer was separated and the aqueous layer was washed 
with ethyl acetate (2 x 20 mL). The combined organic extracts were concentrated under reduced 
pressure, passed through a short pad of silica gel eluting with 20% ethyl acetate:hexanes (50 mL), 
and concentrated again under reduced pressure to afford the crude yellow oil S4 in 92% yield 
which was used in the next step without further purification. 
 A neat mixture of (E)-(6-bromohex-3-en-1-yl)benzene S4 (6 mmol, 1.43 g), dimethyl 
malonate (6 mmol, 1.0 equiv, 0.69 mL), K2CO3 (6.6 mmol, 1.1 equiv, 910 mg) and TBAI (1.8 
mmol, 0.3 equiv, 665 mg) was stirred vigorously at 60 oC  for 24 hrs.  The resultant mixture was 
cooled down to room temperature, diluted with ethyl acetate, filtered, washed with ethyl acetate 
(3 x 5 mL), and concentrated under reduced pressure to give the crude yellow oil S5 in 81% yield 
which was used in the next step without further purification. 
To a solution of dimethyl (E)-2-(6-phenylhex-3-en-1-yl)malonate S5 (2.2 mmol, 635 mg) 
in EtOH:water (5 mL, 4:1) was added KOH (7.2 mmol, 3.2 equiv, 405 mg). The resultant mixture 
was heated to 45 oC. After a 16h stir, the mixture was cooled to room temperature, concentrated 
under reduced pressure and poured into a solution of diethyl ether:hexanes (5 mL, 1:4) and water 
(5 mL). The resulting mixture was acidified with conc. H2SO4 (0.4 mL) and adjusted to pH = 1 by 
dilute HCl (3M). After extraction with EtOAc (3 x 10 mL), the organic layers were combined, 
dried (anhyd. Na2SO4) and concentrated under reduced pressure to give the crude off-white solid 
S6 in 96% yield which was used in the next step without further purification. 
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To a solution of (E)-2-(6-phenylhex-3-en-1-yl)malonic acid S6 (2.1 mmol, 550 mg) in THF 
(5 mL) was added CDI (2.3 mmol, 1.1 equiv, 372 mg) portion wise under positive nitrogen.3 The 
resulting mixture was stirred at room temp for 2h, then benzyl amine (3.2 mmol, 1.5 equiv, 0.35 
mL) was added in one portion. The resultant mixture was refluxed for 3h, cooled to room temp, 
and concentrated under reduced pressure. The obtained residue was then dissolved in 10 mL 
EtOAc and washed with a 10 mL aqueous solution of citric acid monohydrate (2.1 mmol, 1 equiv, 
441 mg) and a saturated sodium bicarbonate (10 mL). The organic extract was dried (anhyd. 
Na2SO4) and concentrated under reduced pressure. Flash chromatography on silica gel (80:20-
60:40 hexanes:ethyl acetate) affords the title compound 9 (473 mg, 73%) as a white solid: m.p. 
67.0–68.0 oC; TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 
7.25–7.40 (7H, m, b,b’,o,o’,p,p’,q), 7.15–7.25 (3H, m, a,c,c’), 5.68 (1H, br s, NH), 5.30–5.50 (2H, 
m, g,h), 4.44 (2H, d, J = 5.7 Hz, m), 2.69 (2H, t, J = 7.4 Hz, e), 2.34 (2H, q, J = 6.6 Hz, f), 2.11 
(2H, t, J = 7.4 Hz, k), 2.04 (2H, q, J = 6.6 Hz, i), 1.65–1.80 (2H, m, j); 13C NMR (100 MHz, 
CDCl3) δ 172.92 (l), 142.08 (d), 138.54 (n), 130.66 (g), 130.17 (h), 128.83 (b,b’), 128.64 (p,p’), 
128.37 (c,c’), 128.00 (o,o’), 127.64 (q), 125.84 (a), 43.70 (m), 36.95 (e), 35.80 (k), 34.19 (f), 31.95 
(i), 25.37 (j); IR (neat) 3290 (N-H stretch), 2924, 2848, 1629 (C=O stretch), 1550 (N-H bend), 
1494, 1452, 726, 693 cm-1; HRMS (ESI) calcd. for C21H25NNaO (M+Na): 330.1834, found 
330.1833 m/z. 
General procedure for the preparation of (E)--unsaturated ethyl esters via Claisen-
Johnson rearrangement (GP2)4 
 
(E)-7-phenyl-4-heptenecarboxylic acid ethyl ester ((E)-8).4 A mixture of 5-phenylpent-
1-en-3-ol (61.6 mmol, 10.1 g), triethyl orthoacetate (93.3 mmol, 1.5 equiv, 17.1 mL), and n-
propanoic acid (6.6 mmol, 0.11 equiv, 0.5 mL) was heated with Dean-Stark apparatus at 160 oC 
for 5h. After cooling to room temperature, the reaction mixture was quenched with satd. NaHCO3 
(10 mL), then dilute with DCM (100 mL) and HCl (1M, 100 mL). After a 2h stir, the organic layer 
was separated, and the aqueous layer was washed with DCM (2 x 50 mL). The organic layers were 
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combined, dried (anhyd. Na2SO4) and concentrated under reduced pressure affords, after flash 
chromatography on silica gel (95:5 hexanes:ethyl acetate), the title compound (11.9 g, 83%) as a 
yellow liquid; TLC analysis Rf  0.4 (90:10 hexanes:ethyl acetate); 1H NMR (400 MHz, CDCl3) δ 
7.30–7.35 (2H, m, b,b’), 7.30–7.35 (3H, m, a,c,c’), 5.45–5.60 (2H, m, g,h), 4.18 (2H, q, J = 7.1 
Hz,, l), 2.72 (2H, t, J = 7.3 Hz, e), 2.30–2.40 (6H, m, f,i,j), 1.30 (3H, t, J = 7.1 Hz, m); 13C NMR 
(100 MHz, CDCl3) δ 173.27 (k), 142.07 (d), 130.85 (h), 128.96 (g), 128.59 (b,b’), 128.39 (c,c’), 
125.90 (a), 60.35 (l), 36.09 (e), 34.49 (j), 34.44 (f), 28.04 (i), 14.42 (m); IR (neat) 2980, 2925, 
1732 (C=O stretch), 1453, 1371, 1247, 1175, 1032, 968, 745, 698 cm-1; HRMS (ESI) calcd. for 
C15H20NaO2 (M+Na): 255.1361, found 255.1364 m/z. 
 The above ester (E)-8 was isolated via column chromatography for screening purpose. All 
other (E)-esters were pass through a short pad of silica gel eluting with 10% EtOAc:hexanes, 
concentrated under reduced pressure, and used without further purification. Note: the reaction was 
typically done under air. For furan-, thiophene-, and pyrrole-containing compounds, it should be 
done under nitrogen to prevent partial decomposition of the products. 
Preparation of (Z)-7-phenyl-4-heptenecarboxylic acid ethyl ester ((Z)-8) via Wittig reaction 
 
The Wittig reagent S7 was prepared from 4-bromobutyricacid ethyl ester and 
triphenylphosphine as previously reported in literature.5 To a cooled (0 oC) solution of S7 (11 
mmol, 5 g) in THF (40 mL) was added NaHMDS (1.1 equiv, 1M, 12 mmol, 12 mL) dropwise. The 
resultant mixture was stirred at 0 oC in 30 mins. After cooling down to -78 oC, 3-phenylpropanal 
(1.1 equiv, 12 mmol, 1.6 mL) was added dropwise. The resultant mixture was slowly warmed to 
room temp and stirred overnight. The reaction was quenched with satd. ammonium chloride (20 
mL) and extracted with EtOAc (3 x 30 mL). The organic layers were combined, washed with brine, 
dried (anhyd. Na2SO4) and concentrated under reduced pressure. The obtained residue was dilute 
with minimum amount of DCM, passed through a short pad of silica gel eluting with 10% 
EtOAc:hexanes, concentrated under reduced pressure to give a crude (Z)-8 as a yellow liquid (1.3 
g, 51%), which was used in the next step without further purification. 
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General procedure for the preparation of allylic alcohol with aldehyde and vinyl magnesium 
bromide (GP3)4 
 
 To a cooled (-78 oC) solution of vinyl magnesium bromide (140 mmol, 1.2 equiv, 1M, 140 
mL) was added 3-phenylpropanal (120 mmol, 16 mL) dropwise. The resultant mixture was slowly 
warmed to room temp and stirred for a total of 3h. After quenching with satd. ammonium chloride, 
it was continued stirring for 15 more mins. The pH was adjusted to 3-4 using dilute HCl (1M). 
After extraction with EtOAc (3 x 100 mL), the organic layers were combined, washed with brine, 
dried (anhyd. Na2SO4) and concentrated under reduced pressure to give the crude yellow liquid 
(18.2 g, 93%) which was used in the next step without further purification. 
The above procedure was applied for all allylic alcohols, except for the two dioxolane-
containing compounds. 




1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)but-3-en-2-ol (S9). The preparation of (4S)-(2,2-
dimethyl-[1,3]-dipxolan-4-yl) acetic acid methyl ester S8 from (L)-malic acid was previously 
reported in literature.6 To the solution of ester S8 (20 mmol, 3.5 g) in DCM (80 mL) was slowly 
added DIBAL-H (1M, 1.2 equiv, 24 mmol, 24 mL) at -78 oC. The resulting mixture was stirred at 
-78 oC for 30 mins, then vinyl magnesium bromide (1M, 1.5 equiv, 30 mmol, 30 mL) was slowly 
added at the same temperature. The resultant mixture was stirred at -78 oC for 30 mins and allowed 
to warm to room temperature and stirred for another 1.5h. The reaction mixture was carefully 
quenched with NaOH (1M, 15 mL). After filtering through a pad of celite, a filtrate was washed 
with water and brine. The organic layer was dried (anhyd. Na2SO4) and carefully concentrated 
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under reduced pressure to give the crude yellow liquid (3.06 g, 89%) which was used in the next 
step without further purification.  
 
1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)prop-2-en-1-ol (S11). The preparation of (1S,2S)-
1,2-bis((R)-2,2-dimethyl-1,3-dioxolan-4-yl)ethane-1,2-diol S10 from (D)-mannitol was 
previously reported in literature.7 To a solution of S10 (21.7 mmol, 5.7 g) in DCM (65 mL) was 
added satd. NaHCO3 (2.6 mL). While the resulting mixture is vigorously stirred, NaIO4 (2 equiv, 
43.4 mmol, 9.3 g) was added portion wise. After stirring at room temp for 4h, the suspension was 
filtered through a pad of celite, flushed with nitrogen, and used in the next step without further 
purification. 
 To the above solution, vinyl magnesium bromide (2.4 equiv with respect to S10, 1M, 52 
mmol, 52 mL) was added slowly at -78 oC. The resultant mixture was stirred at -78 oC for 30 mins 
and allowed to warm to room temperature and stirred for another 1.5h. The reaction mixture was 
carefully quenched with NaOH (1M, 35 mL). After filtering through a pad of celite, a filtrate was 
washed with water and brine. The organic layer was dried (anhyd. Na2SO4) and carefully 
concentrated under reduced pressure to give the crude yellow liquid (4.46 g, 65%) which was used 





Preparations of aldehydes S12–14 and S16 
 
S12,8 S13,9 and S1410 were prepared as described in literature. 
3-(2,5-dimethyl-1H-pyrrol-1-yl)propanal (S16). The solution of 3-aminopropanol (59.7 
mmol, 4.56 mL), 2,5-hexanedione (59.7 mmol, 7.0 mL), and p-toluenesulfonic acid monohydrate 
(0.05 equiv, 3 mmol, 570 mg) in toluene (50 mL) was reflux with Dean-Stark apparatus overnight. 
The resultant mixture was cooled to room temp and washed with water. The organic layer was 
separated and the aqueous layer was extracted with DCM (3 x 20 mL). The organic layers were 
combined, dried (anhyd. Na2SO4) and concentrated under reduced pressure to give crude S15 as a 
brown liquid in (9.1 g, quantitative) which was used in the next step without further purification. 
 To a cooled (0 oC) solution of crude S15 (13.7 mmol, 2.1 g) in DCM (40 mL) was added 
DMSO (6 equiv, 82.1 mmol, 5.8 mL), Et(iPr)2N (3 equiv, 41 mmol, 7.1 mL) and sulfur trioxide 
pyridine complex (2 equiv, 27.4, 4.35 g) sequentially. The resultant mixture was stirred at 0 oC for 
1h before quenching with brine (20 mL). The aqueous layer was washed with Et2O (3 x 20 mL), 
and the combined organic layers were dried (anhyd. Na2SO4) and concentrated under reduced 
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Weinreb amide (6b). To a yellow solution of 2 mol% [Rh(nbd)2BF4/ 2(R)-L1] (i.e., Rh(nbd)2BF4 
(3.9 mg, 0.01 mmol) and (R)-(BINOL)PN(Me)Ph L1 (8.9 mg, 0.021 mmol)) in THF (2.0 mL) was 
added -unsaturated amide 5b (130 mg, 0.528 mmol) as a solution in THF (2.0 mL). To the 
resulting solution was added dropwise a solution of 4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(pinBH, B1, 102 mg, 0.8 mmol) in THF (1.0 mL). The mixture was then stirred at 40 oC for 12h. 
Afterwards, the reaction was concentrated under reduced pressure and purified via flash 
chromatography on silica gel (90:10-50:50 hexanes:ethyl acetate) to afford the title compound 
(136 mg, 69%) as a yellow oil: TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate); [α]D20 = +5.1o 
(c 2.0, CHCl3); 11B NMR (128 MHz, CDCl3) δ 33.87;  1H NMR (400 MHz, CDCl3) δ 7.25–7.30  
(2H, m, b,b’), 7.15–7.25 (3H, m, a,c,c’), 3.67 (3H, s, o), 3.18 (3H, s, n), 2.62 (2H, d, J = 7.6 Hz, 
e), 2.30–2.60 (2H, m, l), 1.40–1.80 (6H, m, f,g,k), 1.26 (12H, s, j,j’,j’’,j’’’), 1.00–1.15 (1H, m, h); 
13C NMR (100 MHz, CDCl3) δ 174.93 (m), 142.89 (d), 128.50 (b,b’), 128.31 (c,c’), 125.63 (a), 
83.09 (i,i’), 61.29 (o), 36.30 (e), 32.28 (n), 31.71 (l), 31.01 (f), 31.00 (g), 26.30 (k), 24.97 and 
24.93 (j,j’,j’’,j’’’); IR (neat) 2976, 2930, 2857, 1663 (C=O stretch), 1380 (C-N stretch), 1314, 
1142, 699 cm-1; HRMS (ESI) calcd. for C21H34BNNaO4 (M+Na): 398.2479, found 398.2496 m/z. 
 
 (S)-7-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)heptanecarboxylic acid 
morpholino amide (6c). Following GP4 with 5c (1.01 g, 3.7 mmol) affords, after flash 
chromatography on silica gel (90:10-40:60 hexanes:ethyl acetate), the title compound (1.22 g, 
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82%) as a yellow oil: TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate); [α]D20 = +0.3o (c 2.0, 
CHCl3); 11B NMR (128 MHz, CDCl3) δ 34.34;  1H NMR (400 MHz, CDCl3) δ 7.25–7.35  (2H, m, 
b,b’), 7.10–7.25 (3H, m, a,c,c’), 3.55–3.70 (6H, m, n,n’,o,o’), 3.40–3.50 (2H, m, n,n’), 2.61 (2H, 
d, J = 7.2 Hz, e), 2.25–2.40 (2H, m, l), 1.40–1.80 (6H, m, f,g,k), 1.24 (12H, s, j,j’,j’’,j’’’), 1.00–
1.10 (1H, m, h); 13C NMR (100 MHz, CDCl3) δ 172.11 (m), 144.78 (d), 128.49 (b,b’), 128.32 
(c,c’), 125.67 (a), 83.17 (i,i’), 67.06 and 66.86 (o,o’), 46.19 and 41.95 (n.n’), 36.25 (e), 33.08 (l), 
30.92 (f), 30.89 (g), 26.99 (k), 25.00 and 24.94 (j,j’,j’’,j’’’); IR (neat) 2974, 2924, 2854, 1644 
(C=O stretch), 1425, 1380 (C-N stretch), 1142, 1114, 699 cm-1; HRMS (ESI) calcd. for 
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benzyl amide (6d). Following GP4 with 0.5 mol% [Rh(nbd)2BF4/ 2(R)-L1] and 5d (1.08 g, 3.7 
mmol) affords, after flash chromatography on silica gel (90:10-40:60 hexanes:ethyl acetate), the 
title compound (1.26 g, 81%) as a yellow oil: TLC analysis Rf 0.3 (60:40 hexanes:ethyl acetate); 
[α]D20 = +2.4o (c 2.0, CHCl3);  11B NMR (128 MHz, CDCl3) δ 34.51; 1H NMR (400 MHz, CDCl3) 
δ 7.30–7.40  (2H, m, q,q’), 7.25–7.30 (5H, m, b,b’,c,c’,r), 7.15–7.25 (3H, m, a,p,p’), 6.00 (1H, br 
s, NH), 4.44 (2H, d, J = 5.8 Hz, n), 2.61 (2H, t, J = 7.6 Hz, e), 2.15–2.30 (2H, m, l), 1.70–1.85 
(2H, m, k), 1.60–1.70 (2H, m, f), 1.50–1.60 (1H, m, g), 1.40–1.50 (1H, m, g), 1.23 (12H, s, 
j,j’,j’’,j’’’), 1.00–1.10 (1H, m, h); 13C NMR (100 MHz, CDCl3) δ 173.19 (m), 142.82 (d), 138.60 
(o), 128.78 (q,q’), 128.51 (b,b’), 128.34 (c,c’), 128.00 (p,p’), 127.55 (r), 125.69 (a), 83.25 (i,i’), 
43.72 (n), 36.50 (l), 36.26 (e), 30.98 (f), 30.94 (g), 27.49 (k), 24.95 (j,j’,j’’,j’’’); IR (neat) 3285 
(N-H stretch), 2976, 2926, 2856, 1644 (C=O stretch), 1541 (N-H bend), 1454, 1379 (C-N stretch), 
1315, 1141, 747, 697 cm-1; HRMS (ESI) calcd. for C26H36BNNaO3 (M+Na): 444.2686, found 
444.2701 m/z.  
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(S)-4-hydroxy-7-phenyl-heptanecarboxylic acid Weinreb amide (7b). Following GP4 
with 5b (130 mg, 0.528 mmol) without purification, the obtained residue was taken up in THF (1.5 
mL and water (1.5 mL). NaBO3-tetrahydrate (231 mg, 1.5 mmol) was added to the resultant 
mixture. After a 5h vigorous stir, the reaction was dilute with water (3 mL) and EtOAc (5 mL). 
The organic layer was separated and the aqueous layer was extract with EtOAc (2 x 3 mL). The 
combined organic layers were dried (anhyd. Na2SO4) and concentrated under reduced pressure 
affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title 
compound (95 mg, 68%) as a colorless oil; TLC analysis Rf  0.5 (0:100 hexanes:ethyl acetate); 
[α]D20 = –12.5o (c 2.0, CHCl3); er of 7b was determined by using harsh oxidation (NaOH/H2O2) 
instead of NaBO3-tetrahydrate to form lactone 23 followed by Al(Me)3-assisted transamidation 
with benzyl amine to generate 7d (procedures described vide infra): Chiral HPLC analysis 
(Chiralpak-IC, 60:40 hexanes:isopropanol, flow rate = 1.3 mL/min) showed peaks at 26 minutes 
(4.0% (R)) and 30 minutes (96.0% (S)); 1H NMR (400 MHz, CDCl3) δ 7.25–7.30 (2H, m, b,b’), 
7.15–7.25 (3H, m, a,c,c’), 3.70 (3H, s, m), 3.60–3.70 (1H, m, h, overlapping with m), 3.20 (3H, s, 
l),  2.74 (1H, br s, OH), 2.66 (2H, t, J = 7.6 Hz, e), 2.50–2.70 (2H, m, j, overlapping with e), 1.80–
1.90 (2H, m, f,i), 1.65–1.75 (2H, m, f,i), 1.45–1.65 (2H, m, g); 13C NMR (100 MHz, CDCl3) δ 
175.19 (k), 142.55 (d), 128.54 (b,b’), 128.38 (c,c’), 125.78 (a), 71.45 (h), 61.35 (m), 37.36 (g), 
35.99 (e), 32.37 (l), 31.74 (i), 28.63 (j), 27.62 (f); IR (neat) 3430 (O-H stretch), 2933, 2858, 1639 
(C=O stretch), 1452, 1416, 1386, 1177, 994, 748, 699 cm-1; HRMS (ESI) calcd. for C15H23NNaO3 
(M+Na): 288.1576, found 288.1583 m/z. 
 
(S)-4-hydroxy-7-phenyl-heptanecarboxylic acid morpholino amide (7c). Following 
GP5 with 5c (144 mg, 0.528 mmol) affords, after flash chromatography on silica gel (80:20-70:30 
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hexanes:ethyl acetate, then switch to 50:50-20:80 hexanes:acetone), the title compound (125 mg, 
81%) as a colorless oil; TLC analysis Rf  0.7 (20:80 hexanes:acetone); [α]D20 = –5.1o (c 2.0, CHCl3); 
er of 7c was determined by boric acid-catalyzed transamidation with benzyl amine to form 7d:11 
Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flow rate = 1.3 mL/min) showed 
peaks at 28 minutes (5.5 0% (R)) and 31 minutes (94.5% (S); 1H NMR (400 MHz, CDCl3) δ 7.25–
7.30 (2H, m, b,b’), 7.15–7.20 (3H, m, a,c,c’), 3.55–3.70 (7H, m, h,l,l’,m,m’), 3.40–3.50 (2H, m, 
l,l’),  2.64 (2H, t, J = 7.6 Hz, e), 2.46 (2H, t, J = 7.0 Hz, j), 1.75–1.90 (2H, m, f,i), 1.60–1.75 (2H, 
m, f,i), 1.45–1.60 (2H, m, g); 13C NMR (100 MHz, CDCl3) δ 172.44 (k), 142.50 (d), 128.53 (b,b’), 
128.39 (c,c’), 125.83 (a), 71.28 (h), 66.95 and 66.68 (m,m’), 46.11 and 42.14 (l,l’), 37.44 (g), 35.97 
(e), 32.11 (i), 29.75 (j), 27.62 (f); IR (neat) 3418 (O-H stretch), 2919, 2855, 1622 (C=O stretch), 
1432, 1271, 1232, 1114, 1068, 1031, 748, 699 cm-1; HRMS (ESI) calcd. for C17H25NNaO3 
(M+Na): 314.1732, found 314.1743 m/z. 
General procedure for CAHB-oxidation sequence with H2O2 (GP6). 
 
(S)-4-hydroxy-7-phenyl-heptanecarboxylic acid phenyl amide (7a). Following GP4 
with 0.5 mol% [Rh(nbd)2BF4/ 2(R)-L1] and 5a (148 mg, 0.528 mmol) without purification, the 
resultant mixture was diluted with THF (10 mL) followed by addition of methanol (8 mL), sodium 
hydroxide (6 mL of a 3.0 M soln.), and the slow addition of H2O2 (1.0 mL of a 30% solution). The 
resulting mixture stirred (2 h) and then extracted with dichloromethane (3 x 15 mL). The combined 
organic extracts were dried (anhyd. Na2SO4) and concentrated under reduced pressure. Flash 
chromatography on silica gel (90:10-40:60 hexanes:ethyl acetate) affords the title compound (124 
mg, 79%) as a white solid: m.p. 119.5–120.5 ºC; TLC analysis Rf 0.3 (40:60 hexanes:ethyl acetate); 
[α]D20 = +7.5o (c 1.0, MeOH); Chiral HPLC analysis (Chiralpak-IB, 70:30 hexanes:isopropanol, 
flow rate = 1.4 mL/min) showed peaks at 41 minutes (3.0% (R)) and 44 minutes (97.0% (S); 1H 
NMR (400 MHz, CDCl3) δ 7.70 (1H, br s, NH), 7.51 (2H, d, J = 7.7 Hz, c,c’), 7.25–7.35 (4H, m, 
b,b’,m,m’), 7.15–7.25 (3H, m, b,b’,n,n’,o), 7.12 (1H, t, J = 7.3 Hz, a), 3.60–3.80 (1H, m, h), 2.65 
(2H, t, J = 7.8 Hz, k), 2.45–2.60 (3H, m, f, OH), 1.90–2.00 (1H, m, g), 1.70–1.85 (3H, m, g,j), 
S24 
 
1.50–1.60 (2H, m, i); 13C NMR (100 MHz, CDCl3) δ 172.03 (e), 142.34 (l), 137.98 (d), 129.11 
(b,b’), 128.53 (n,n’), 128.44 (m,m’), 125.90 (o), 124.43 (a), 120.02 (c,c’), 71.46 (h), 37.41 (i), 
35.91 (k), 34.32 (f), 32.48 (g), 27.55 (j); IR (neat) 3670 (N-H stretch, O-H stretch), 3279, 3247, 
2950, 2911, 1659 (C=O stretch), 1600 (N-H bend), 1543, 1496, 1412 (C-N stretch), 754, 689 cm-
1; HRMS (ESI) calcd. for C19H23NNaO2 (M+Na): 320.1626, found 320.1631 m/z. 
 
(S)-4-hydroxy-7-phenyl-4-heptanecarboxylic acid benzyl amide (7d). Following GP6 
with (E)-5d (155 mg, 0.528 mmol) affords, after flash chromatography on silica gel (80:20-20:80 
hexanes:ethyl acetate), the title compound (131 mg, 80%) as a white solid: m.p. 88.5–89.5 ºC; 
TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20 = –7.9o (c 1.0, CHCl3); Chiral HPLC 
analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flow rate = 1.3 mL/min) showed peaks at 28 
minutes (3.5% (R)) and 32 minutes (96.5% (S); 1H NMR (400 MHz, CDCl3) δ 7.10–7.40 (10H, 
a,b,b’,c,c’,n,n’,o,o’,p), 6.28 (1H, br s, NH), 4.40 (2H, d, J = 5.7 Hz, e), 3.55–3.70 (1H, m, i), 3.19 
(1H, d, J = 4.2 Hz, OH), 2.64 (2H, t, J = 7.6 Hz, l), 2.36 (2H, td, J = 7.3 and 2.8 Hz, g), 1.70–1.90 
(2H, m, h,k), 1.60–1.70 (2H, m, h,k), 1.40–1.60 (2H, m, j); 13C NMR (100 MHz, CDCl3) δ 173.76 
(f), 142.48 (m), 138.30 (d), 128.82 (b,b’), 128.54 (o,o’), 128.42 (n,n’), 127.89 (c,c’), 127.64 (a), 
125.85 (p), 71.29 (i), 43.79 (e), 37.31 (j), 35.95 (l), 33.23 (g), 32.72 (h), 27.61 (k); IR (neat) 3306 
(N-H stretch, O-H stretch), 3025, 2937, 2919, 2867, 1637 (C=O stretch), 1546 (N-H bend), 1495, 
1442, 1234, 724, 694 cm-1; HRMS (ESI) calcd. for C20H25NNaO2 (M+Na): 334.1783, found 
334.1781 m/z. 
Following GP6 with (Z)-5d (155 mg, 0.528 mmol) affords, after flash chromatography on 
silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound (128 mg, 78%) as a white solid: 
m.p. 88.0–99.5 ºC; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20 = –7.8o (c 1.0, CHCl3); 
Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flow rate = 1.3 mL/min) showed 
peaks at 27 minutes (6.0% (R)) and 31 minutes (94.0% (S); spectroscopic data matched with (S)-




(S)-7-(furan-2-yl)-4-hydroxyheptanecarboxylic acid benzyl amide (7e).d Following 
GP6 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-L1] and 5e (150 mg, 0.528 mmol) affords, after flash 
chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound (113 mg, 
71%) as a light yellow solid: m.p. 72.5–74.0 ºC; TLC analysis Rf 0.35 (0:100 hexanes:ethyl 
acetate); [α]D20 = –6.1o (c 2.0, CHCl3); Chiral HPLC analysis (Chiralpak-IB, 60:40 
hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 18 minutes (94.0% (S)) and 47 
minutes (6.0% (R));  1H NMR (400 MHz, CDCl3) δ 7.20–7.40 (6H, a,b,b’,c,c’,p), 6.29 (1H, dd, J 
= 2.9 and 2.0 Hz, o), 6.26 (1H, br s, NH, overlapping with o), 6.00 (1H, d, J = 3.0 Hz, n), 4.42 
(2H, d, J = 5.7 Hz, e), 3.55–3.70 (1H, m, i), 2.85–3.45 (1H, br s, OH), 2.65 (2H, t, J = 7.4 Hz, l), 
2.38 (2H, td, J = 7.2 and 3.4 Hz, g), 1.75–1.90 (2H, m, h,k), 1.60–1.75 (2H, m, h,k), 1.40–1.60 
(2H, m, j); 13C NMR (100 MHz, CDCl3) δ 173.72 (f), 156.17 (m), 140.86 (p), 138.28 (d), 128.83 
(b,b’), 127.90 (c,c’), 127.65 (a), 110.20 (o), 104.97 (n), 71.16 (i), 43.80 (e), 43.79 (e), 37.16 (j), 
33.25 (g), 32.70 (h), 27.98 (l), 24.33 (k); IR (neat) 3288 (N-H stretch, O-H stretch), 2919, 1632 
(C=O stretch), 1534, 1453, 1090, 1006, 723, 695 cm-1; HRMS (ESI) calcd. for C18H23NNaO3 
(M+Na): 324.1576, found 324.1573 m/z. 
 
(S)-4-hydroxy-7-(thiophen-2-yl)-heptanecarboxylic acid benzyl amide (7f).e Following 
GP6 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-L1] and 5f (158 mg, 0.528 mmol) affords, after flash 
chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound (121 mg, 
72%) as a white solid: m.p. 73.5–74.5 ºC; TLC analysis Rf 0.35 (0:100 hexanes:ethyl acetate); 
[α]D20 = –4.7o (c 1.5, CHCl3); Chiral HPLC analysis (Chiralpak-IB, 60:40 hexanes:isopropanol, 
                                                            
d A pseudo-racemate was prepared for HPLC analysis by combining crude reactions mixtures obtained by CAHB 
using (R)- and (S)-L1 then oxidizing and isolating the resulting alcohol 
e A pseudo-racemate was prepared for HPLC analysis by combining crude reactions mixtures obtained by CAHB 
using (R)- and (S)-L1 then oxidizing and isolating the resulting alcohol 
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flowrate = 1.4 mL/min) showed peaks at 28 minutes (94.0% (S)) and 109 minutes (6.0% (R)); 1H 
NMR (400 MHz, CDCl3) δ 7.35–7.40 (2H, b,b’), 7.25–7.35 (3H, a,c,c’), 7.12 (1H, dd, J = 5.1 and 
1.0 Hz, p), 6.93 (1H, dd, J = 5.0 and 3.4 Hz, o), 6.80 (1H, dd, J = 3.3 and 0.8 Hz, n), 6.16 (1H, br 
s, NH), 4.43 (2H, d, J = 5.7 Hz, e), 3.60–3.70 (1H, m, i), 2.86 (2H, t, J = 7.5 Hz, l), 2.39 (2H, td, 
J = 7.2 and 3.8 Hz, g), 1.80–1.90 (2H, m, h,k), 1.65–1.80 (2H, m, h,k), 1.45–1.60 (2H, m, j); 13C 
NMR (100 MHz, CDCl3) δ 173.67 (f), 145.36 (m), 138.26 (d), 128.85 (b,b’), 127.92 (c,c’), 127.68 
(a), 126.82 (o), 124.27 (n), 123.02 (p), 71.20 (i), 43.84 (e), 37.11 (j), 33.27 (g), 32.68 (h), 29.94 
(l), 27.97 (k); IR (neat) 3291 (N-H stretch, O-H stretch), 2917, 2849, 1630 (C=O stretch), 1534, 
1453, 691 cm-1; HRMS (ESI) calcd. for C18H23NNaO2S (M+Na): 340.1347, found 340.1354 m/z. 
 
(S)-7-(2,5-dimethyl-1H-pyrrol-1-yl)-4-hydroxyheptanecarboxylic acid benzyl amide 
(7g).f Following GP6 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-L1] and 5g (164 mg, 0.528 mmol) 
affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title 
compound (102 mg, 59%) as a yellow oil; TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20 
= –7.1o (c 1.8, CHCl3); Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flowrate 
= 1.4 mL/min) showed peaks at 42 minutes (8.0% (R)) and 54 minutes (92.0% (S));  1H NMR (400 
MHz, CDCl3) δ 7.25–7.40 (5H, a,b,b’,c,c’), 6.10 (1H, br s, NH), 5.78 (2H, s, n,n’), 4.43 (2H, d, J 
= 5.7 Hz, e), 3.77 (2H, t, J = 7.6 Hz, l), 3.55–3.70 (1H, m, i), 2.30–2.45 (2H, m, g), 2.24 (6H, s, 
o,o’), 1.75–1.90 (2H, m, h,k), 1.65–1.75 (2H, m, h,k), 1.45–1.55 (2H, m, j); 13C NMR (100 MHz, 
CDCl3) δ 173.61 (f), 138.17 (d), 128.87 (b,b’), 127.92 (c,c’), 127.72 (a), 127.48 (m,m’), 105.19 
(n,n’), 71.14 (i), 43.87 (e), 43.60 (l), 34.82 (j), 33.22 (g), 32.66 (h), 27.36 (k), 12.68 (o,o’); IR 
(neat) 3285 (N-H stretch, O-H stretch), 2923, 1643 (C=O stretch), 1541, 1453, 1407, 1298, 742, 
697 cm-1; HRMS (ESI) calcd. for C20H28N2NaO2 (M+Na): 351.2048, found 351.2059 m/z. 
                                                            
f A pseudo-racemate was prepared for HPLC analysis by combining crude reactions mixtures obtained by CAHB 




(S)-4-hydroxy-6-methylheptanecarboxylic acid benzyl amide (7h). Following GP6 
with 5h (122 mg, 0.528 mmol) affords, after flash chromatography on silica gel (80:20-20:80 
hexanes:ethyl acetate), the title compound (88 mg, 67%) as a white solid: m.p. 50.5–51.5 ºC; TLC 
analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20 = –18.4o (c 2.0, CHCl3); Chiral HPLC analysis 
(Chiralpak-IC, 90:10 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 96 minutes 
(3.0% (R)) and 103 minutes (97.0% (S));  1H NMR (400 MHz, CDCl3) δ 7.30–7.40 (2H, b,b’), 
7.25–7.30 (3H, a,c,c’), 6.21 (1H, br s, NH), 4.43 (2H, d, J = 5.7 Hz, e), 3.65–3.75 (1H, m, i), 2.60–
3.00 (1H, br s, OH), 2.40 (2H, td, J = 7.6 and 2.6 Hz, g), 1.80–1.90 (1H, m, h), 1.70–1.80 (1H, m, 
k), 1.60–1.70 (1H, m, h), 1.40–1.50 (1H, m, j), 1.20–1.25 (1H, m, j), 0.92 (6H, dd, J = 6.2 and 5.4 
Hz, l,l’); 13C NMR (100 MHz, CDCl3) δ 173.70 (f), 138.34 (d), 128.82 (b,b’), 127.89 (c,c’), 127.63 
(a), 69.42 (i), 47.04 (j), 43.79 (e), 33.26 (h), 33.24 (g), 24.73 (k), 23.47 and 22.28 (l.l’); IR (neat) 
3284 (N-H stretch, O-H stretch), 2952, 2916, 2868, 1643 (C=O stretch), 1546, 1453, 696 cm-1; 
HRMS (ESI) calcd. for C15H23NNaO2 (M+Na): 272.1626, found 272.1638 m/z. 
 
(S)-4-hydroxy-7-methyloctanecarboxylic acid benzyl amide (7i). Following GP6 with 
5i (130 mg, 0.528 mmol) affords, after flash chromatography on silica gel (80:20-20:80 
hexanes:ethyl acetate), the title compound (104 mg, 75%) as a white solid: m.p. 61.0–62.0 ºC; 
TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate); [α]D20 = –5.9o (c 2.0, CHCl3); Chiral HPLC 
analysis (Chiralcel-OD, 60:40 hexanes:isopropanol, flowrate = 1.0 mL/min) showed peaks at 11 
minutes (96.5% (S)) and 16 minutes (3.5% (R)); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, 
b,b’), 7.20–7.30 (a,c,c’), 6.49 (1H, br s, NH), 4.39 (2H, d, J = 5.7 Hz, e), 3.50–3.60 (1H, m, i), 
3.26 (1H, br s, OH), 2.30–2.45 (2H, m, g), 1.80–1.90 (1H, m, h), 1.60–1.70 (1H, m, h), 1.50–1.60 
(1H, m, l), 1.40–1.50 (2H, m, j), 1.25–1.35 (1H, m, k), 1.15–1.25 (1H, m, k) 0.89 (6H, dd, J = 6.6 
and 1.6 Hz, m,m’); 13C NMR (100 MHz, CDCl3) δ 173.90 (f), 138.36 (d), 128.78 (b,b’), 127.84 
(c,c’), 127.57 (a), 71.72 (i), 43.72 (e), 35.60 (j), 34.97 (k), 33.23 (g), 32.75 (h), 28.20 (l), 22.76 
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and 22.68 (m,m’); IR (neat) 3452 (N-H stretch), 3294 (O-H stretch), 2951. 2931, 2901, 2868, 1615 
(C=O stretch), 1545, 1454, 1249, 1063, 1029, 723, 692 cm-1; HRMS (ESI) calcd. for C16H25NNaO2 
(M+Na): 286.1783, found 286.1785 m/z. 
 
(4S,7S)-4-hydroxy-7,11-dimethyl-10-dodecenecarboxylic acid benzyl amide ((4S,7S)-
7j). Following GP6 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-L1] and 5j (167 mg, 0.528 mmol) affords, 
after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound 
(137 mg, 78%) as a white solid: m.p. 72.0–73.0 ºC; TLC analysis Rf 0.5 (0:100 hexanes:ethyl 
acetate); [α]D20 = –2.5o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.20–7.40 (5H, a,b,b’,c,c’), 
6.30 (1H, br s, NH), 5.11 (1H, t, J = 5.8 Hz, p), 4.42 (2H, d, J = 5.5 Hz, e), 3.45–3.65 (1H, m, i), 
3.05 (1H. br s, OH), 2.30–2.45 (2H, m, g), 1.80–2.05 (3H, m, o,h), 1.70 (3H, s, r), 1.62 (3H, s, s), 
1.20–1.50 (6H, m, h,j,l,n), 1.15–1.20 (2H, m, k), 0.89 (3H, d, J = 5.5 Hz, m); 13C NMR (100 MHz, 
CDCl3) δ 173.77 (f), 138.33 (d), 131.19 (q), 128.80 (b,b’), 127.88 (c,c’), 127.61 (a), 125.01 (p), 
71.92 (major diastereomer, 92%, i), 71.82 (minor diastereomer, 8%, i), 43.78 (e), 37.19 (minor 
diastereomer, 7%, l), 37.12 (major diastereomer, 93%, l), 35.29 (n), 33.26 (g), 32.99 (h), 32.65 (j 
and k overlapping), 25.83 (r), 25.64 (o), 19.67 (m), 17.77 (s); IR (neat) 3300 (N-H stretch, O-H 
stretch), 2962, 2911, 2849, 1642 (C=O stretch), 1552, 1452, 1344, 1256, 695 cm-1; HRMS (ESI) 
calcd. for C21H33NNaO2 (M+Na): 354.2409, found 354.2414 m/z. 
 
(4R,7S)-4-hydroxy-7,11-dimethyl-10-dodecenecarboxylic acid benzyl amide ((4R,7S)-
7j). Following GP6 with 1.0 mol% [Rh(nbd)2BF4/ 2(S)-L1] and 5j (167 mg, 0.528 mmol) affords, 
after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl acetate), the title compound 
(133 mg, 76%) as a white semi-solid; TLC analysis Rf 0.5 (0:100 hexanes:ethyl acetate); [α]D20 = 
+6.5o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, 
a,c,c’), 6.30 (1H, br s, NH), 5.11 (1H, t, J = 6.2 Hz, p), 4.42 (2H, d, J = 5.7 Hz, e), 3.45–3.70 (1H, 
m, i), 3.04 (1H. br s, OH), 2.30–2.45 (2H, m, g), 1.80–2.05 (3H, m, o,h), 1.70 (3H, s, r), 1.62 (3H, 
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s, s), 1.20–1.50 (7H, m, h,j,k,l,n), 1.10–1.20 (1H, m, k), 0.89 (3H, d, J = 6.4 Hz, m); 13C NMR 
(100 MHz, CDCl3) δ 173.77 (f), 138.33 (d), 131.19 (q), 128.80 (b,b’), 127.88 (c,c’), 127.61 (a), 
125.02 (p), 71.92 (minor diastereomer, 7%, i), 71.82 (major diastereomer, 93%, i), 43.78 (e), 37.19 
(major diastereomer, 92%, l), 37.12 (minor diastereomer, 8%, l), 35.28 (n), 33.29 (g), 32.94 (h), 
32.75 k), 32.58 (j), 25.83 (r), 25.65 (o), 19.61 (m), 17.77 (s); IR (neat) 3271 (N-H stretch, O-H 
stretch), 2912, 2851, 1651 (C=O stretch), 1616, 1538 1453, 727, 694 cm-1; HRMS (ESI) calcd. for 
C21H33NNaO2 (M+Na): 354.2409, found 354.2412 m/z. 
 
(S)-4-hydroxy-7((triisopropylsilyl)oxy)heptanecarboxylic acid benzyl amide (7k). 
Following GP6 with 5k (206 mg, 0.528 mmol) affords, after flash chromatography on silica gel 
(80:20-20:80 hexanes:ethyl acetate), the title compound (168 mg, 78%) as a colorless oil; TLC 
analysis Rf 0.4 (20:80 hexanes:ethyl acetate); [α]D20 = +7.1o (c 2.0, CHCl3); Chiral HPLC analysis 
(Chiralpak-IC, 80:20 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 29 minutes 
(3.0% (R)) and 35 minutes (97.0% (S));  1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, b,b’), 7.25–
7.30 (3H, a,c,c’), 6.28 (1H, br s, NH), 4.44 (2H, dd, J = 5.6 and 3.2 Hz, e), 3.70–3.85 (3H, m, l, 
OH), 3.60–3.70 (1H, m, i),  2.42 (2H, t, J = 7.0 Hz, g), 1.85–1.95 (1H, m, h), 1.60–1.80 (4H, m, 
h,j,k), 1.50–1.60 (1H, m, j), 1.00–1.15 (3H, m, m,m’,m’’, overlapping with n,n’,n’’), 1.08 (18H, s, 
n,n’,n’’); 13C NMR (100 MHz, CDCl3) δ 173.61 (f), 138.48 (d), 128.77 (b,b’), 127.88 (c,c’), 127.54 
(a), 71.14 (i), 63.95 (l), 43.74 (e), 35.37 (j), 33.46 (g), 32.89 (h), 29.60 (k), 18.08 (n,n’,n’’), 12.02 
(m,m’,m’’); IR (neat) 3289 (N-H stretch, O-H stretch), 2941, 2864, 1644 (C=O stretch), 1548, 
1454, 1097, 881, 679 cm-1; HRMS (ESI) calcd. for C23H41NNaO3Si (M+Na): 430.2753, found 
430.2763 m/z. 
 
(S,S)-4-hydroxy-6-(2,2-dimethyl-1,3-dioxolan-4-yl)hexanecarboxylic acid benzyl 
amide ((S,S)-7l). Following GP6 with 1.0 mol% [Rh(nbd)2BF4/ 2(R)-L1] and 5l (160 mg, 0.528 
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mmol) affords, after flash chromatography on silica gel (70:30-0:100 hexanes:ethyl acetate), the 
title compound (122 mg, 72%) as a colorless oil; TLC analysis Rf 0.25 (0:100 hexanes:ethyl 
acetate); [α]D20 = +10.1o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 
7.25–7.30 (3H, m, a,c,c’), 6.27 (1H, br s, NH), 4.42 (2H, d, J = 5.7 Hz, e), 4.05–4.15 (1H, m, l), 
4.05 (1H, dd, J = 6.0 and 6.0 Hz, m), 3.60–3.70 (1H, m, i), 3.53 (1H, dd, J = 7.5 and 7.5 Hz, m), 
3.08 (1H. br s, OH), 2.40 (2H, t, J = 6.6 Hz, g), 1.80–1.90 (1H, m, h), 1.60–1.80 (3H, m, h,k), 
1.50–1.60 (2H, m, j), 1.41 (3H, s, o,o’), 1.36 (3H, s, o,o’); 13C NMR (100 MHz, CDCl3) δ 173.62 
(f), 138.32 (d), 128.81 (b,b’), 127.87 (c,c’), 127.61 (a), 109.08 (n), 76.22 (l), 71.17 (major 
diastereomer, 96%, i), 71.02 (minor diastereomer, 4%, i), 69.56 (major diastereomer, 96%, m), 
69.54 (minor diastereomer, 4%, m), 43.78 (e), 34.19 (major diastereomer, 95%, j), 34.01 (minor 
diastereomer, 5%, j), 33.28 (g), 32.86 (h), 30.23 (k), 27.01 (o,o’), 25.83 (o,o’); IR (neat) 3298 (N-
H stretch, O-H stretch), 2984, 2932, 2868, 1644 (C=O stretch), 1543, 1454, 1369, 1214, 1155, 
1053, 698 cm-1; HRMS (ESI) calcd. for C18H27NNaO4 (M+Na): 344.1838, found 344.1847 m/z. 
 
(S,S)-4-hydroxy-6-(2,2-dimethyl-1,3-dioxolan-4-yl)hexanecarboxylic acid benzyl 
amide ((S,S)-7l). Following GP6 with 1.0 mol% [Rh(nbd)2BF4/ 2(S)-L1] and 5l (160 mg, 0.528 
mmol) affords, after flash chromatography on silica gel (70:30-0:100 hexanes:ethyl acetate), the 
title compound (122 mg, 72%) as a colorless oil; TLC analysis Rf 0.25 (0:100 hexanes:ethyl 
acetate); [α]D20 = +22.3o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 
7.20–7.30 (3H, m, a,c,c’), 6.44 (1H, br s, NH), 4.39 (2H, d, J = 5.7 Hz, e), 4.05–4.15 (1H, m, l), 
4.02 (1H, dd, J = 7.6 and 7.6 Hz, m), 3.55–3.75 (2H, m, i, OH), 3.50 (1H, dd, J = 7.2 and 7.2 Hz, 
m), 2.36 (1H, t, J = 6.0 Hz, g), 1.80–1.90 (1H, m, h), 1.55–1.80 (4H, m, h,j,k), 1.45–1.50 (1H, m, 
j), 1.40 (3H, s, o,o’), 1.35 (3H, s, o,o’); 13C NMR (100 MHz, CDCl3) δ 173.68 (f), 138.28 (d), 
128.75 (b,b’), 127.79 (c,c’), 127.55 (a), 108.93 (n), 76.21 (l), 71.06 (minor diastereomer, 5%, i), 
70.95 (major diastereomer, 95%, i), 69.61 (minor diastereomer, 5%, m), 69.51 (major 
diastereomer, 95%, m), 43.69 (e), 34.19 (minor diastereomer, 0%, j), 33.94 (major diastereomer, 
100%, j), 33.18 (g), 32.73 (h), 29.79 (k), 26.99 (o,o’), 25.79 (o,o’); IR (neat) 3294 (N-H stretch, 
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O-H stretch), 2984, 2931, 2869, 1644 (C=O stretch), 1542, 1454, 1369, 1214, 1054, 698 cm-1; 
HRMS (ESI) calcd. for C18H27NNaO4 (M+Na): 344.1838, found 344.1851 m/z. 
 
(R,S)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)-4hydroxypentanecarboxylic acid benzyl 
amide ((R,S)-7m). Following GP6 with 1.0 mol% [Rh(nbd)2BF4/ 2(S)-L1] and 5m (153 mg, 0.528 
mmol) affords, after flash chromatography on silica gel (70:30-0:100 hexanes:ethyl acetate), the 
title compound (114 mg, 70%) as a colorless oil; TLC analysis Rf 0.25 (0:100 hexanes:ethyl 
acetate); [α]D20 = –3.5o (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 
7.20–7.30 (3H, m, a,c,c’), 6.37 (1H, br s, NH), 4.40 (2H, d, J = 5.7 Hz, e), 4.25–4.35 (1H, m, k), 
4.07 (1H, dd, J = 8.0 and 6.1 Hz, l), 3.80–3.90 (1H, m, i), 3.55 (1H, dd, J = 7.8 and 7.8 Hz, l), 2.39 
(1H, t, J = 6.9 Hz, g), 1.80–1.90 (1H, m, h), 1.60–1.80 (3H, m, h,j), 1.40 (3H, s, n,n’), 1.35 (3H, 
s, n,n’); 13C NMR (100 MHz, CDCl3) δ 173.60 (f), 138.27 (d), 128.81 (b,b’), 127.86 (c,c’), 127.62 
(a), 108.81 (m), 73.79 (k), 69.66 (major diastereomer, 92%, i), 69.49 (minor diastereomer, 8%, i), 
68.58 (l), 43.77 (e), 40.67 (minor diastereomer, 7%, j), 40.56 (major diastereomer, 93%, j), 33.15 
(g), 33.08 (h), 27.03 (n,n’), 25.78 (n,n’); IR (neat) 3304 (N-H stretch, O-H stretch), 2984, 2935, 
2873, 1644 (C=O stretch), 1542, 1454, 1369, 1214, 1155, 1052, 698 cm-1; HRMS (ESI) calcd. for 
C17H25NNaO4 (M+Na): 330.1681, found 330.1690 m/z. 
 
(S)-4-hydroxy-hexanecarboxylic acid benzyl amide (7n). Following GP6 with 5n (107 
mg, 0.528 mmol) affords, after flash chromatography on silica gel (80:20-20:80 hexanes:ethyl 
acetate), the title compound (71 mg, 61%) as a white solid: m.p. 63.5–64.5 oC; TLC analysis Rf 
0.4 (0:100 hexanes:ethyl acetate); [α]D20 = +5.3o (c 1.44, CHCl3); 1H NMR (300 MHz, CDCl3) δ 
7.20–7.40 (5H, a,b,b’,c,c’), 6.48 (1H, br s, NH), 4.40 (2H, d, J = 5.2 Hz, e), 3.40–3.60 (1H, m, i), 
3.21 (1H, br s, OH), 2.37 (2H, t, J = 6.5 Hz, g) 1.75–1.95 (1H, m, h), 1.55–1.75 (1H, m, h), 1.40–
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1.55 (2H, m, j), 0.93 (3H, t, J = 7.2 Hz, k); 13C NMR (75 MHz, CDCl3) δ 173.80 (f), 138.24 (d), 
128.67 (b,b’), 127.74 (c,c’), 127.46 (a), 72.67 (i), 43.62 (e), 33.12 (g), 32.16 (h), 30.40 (j), 10.02 
(k); IR (neat) 3280 (N-H stretch, O-H stretch), 2964, 2920, 2877, 1631 (C=O stretch), 1549 (N-H 
bend), 1493, 1326, 1264, 936, 729, 693 cm-1; HRMS (ESI) calcd. for C13H19NNaO2 (M+Na): 
244.1313, found 244.1316 m/z. 
Er of 7n was determined by 19F NMR of the corresponding Mosher ester (S,S)-S17. 
 
(S)-6-(benzylamino)-6-oxohexan-3-yl (S)-3,3,3-trifluoro-2-methoxy-2-
phenylpropanoate ((S,S)-S17). To a solution of 7n (0.06 mmol, 13.2 mg) and (S)-Mosher acid 
(3.1 equiv, 0.186 mmol, 44 mg) in DCM (1 mL) was added DCC (3.1 equiv, 0.186 mmol, 38.6 
mg) and DMAP (3.1 equiv, 0.186 mmol, 22.8 mg). The resultant mixture was stirred at room temp 
for 5h then concentrated under vacuum. Flash column chromatography (80:20-50:50 
hexanes:ethyl acetate) affords the title compound (24 mg, 92%)  as a white semi-solid; TLC 
analysis Rf 0.5 (50:50 hexanes:ethyl acetate); [α]D20 = –34.5o (c 1.87, CHCl3); 19F NMR (376 MHz, 
CDCl3) δ –71.01 (s, 5%, minor, CF3), –71.08 (s, 95%, major, CF3); 1H NMR (400 MHz, CDCl3) δ 
7.50–7.60 (2H, m, r,r’), 7.25–7.45 (8H, a,b,b’,c,c’,q,q’,s), 5.74 (0.94H, br s, major NH), 5.52 
(0.05H, br s, minor NH), 5.00–5.15 (1H, m, i),  4.44 (2H, d, J = 5.7 Hz, e), 3.54 (3H, s, n), 2.05–
2.30 (3H, m, g,h), 1.95–2.05 (1H, m, h), 1.60–1.70 (2H, m, j), 0.96 (0.12H, t, J = 7.4 Hz, minor 
k), 0.86 (2.89H, t, J = 7.4 Hz, major k); 13C NMR (100 MHz, CDCl3) δ 171.60 (f), 166.59 (l), 
138.26 (d), 132.26 (p), 129.74 (r,r’), 128.85 (b,b’), 128.57 (q,q’), 127.98 (c,c’), 127.70 (s), 127.54 
(a), 123.50 (q, J = 287 Hz, o), 84.79 and 84.52 (m), 78.16 (i), 55.47 (n), 43.82 (e), 32.21 (g), 29.38 
(h), 26.82 (j), 9.37 (k); IR (neat) 3293 (N-H stretch), 2970, 2935, 1741 (C=O stretch), 1644 (C=O 
stretch), 1545 (N-H bend), 1452, 1258, 1165, 1121, 1016, 992, 715, 696 cm-1; HRMS (ESI) calcd. 
for C23H26F3NNaO4 (M+Na): 460.1712, found 460.1729 m/z. 




  (S)-7-phenyl-4-(trifluoroborato)heptanecarboxylic acid morpholino amide, cesium 
salt (11c). To a solution of -dioxaborato amide 6c (803 mg, 2.0 mmol, 1.0 equiv) in acetonitrile 
(MeCN, 8.0 mL) was added a solution of CsF (1.21 g, 8.0 mmol, 4.0 equiv) in H2O (0.8 mL). The 
resultant mixture was stirred at room temp for 2 mins, and a solution of L-(+)-tartaric acid (614 
mg, 4.1 mmol, 2.05 equiv) in THF (3.0 mL) was added dropwise. After a 5 h stir, the mixture was 
filtered, washed through with more MeCN, and the filtrate was concentrated under reduced 
pressure to afford the crude mixture of trifluorborate salt. Afterward, diethyl ether was added to 
the crude mixture to dissolve undesired products. Following a decantation to remove the solvent 
and undesired products, the precipitate was further dried under vacuum to afford the title 
compound (874 mg, 92%) as an off-white foamy solid: mp 61.5–62.5 ºC; [α]D20 = +0.5o (c 1.0, 
CHCl3); 19F NMR (376 MHz, CDCl3) δ –133.36 (s, BF3Cs); 1H NMR (400 MHz, CDCl3) δ 7.25–
7.30 (2H, m, b,b’), 7.15–7.20 (3H, m, a,c,c’), 3.55–3.60 (4H, m, m,m’), 3.45–3.55 (2H, m, l,l’), 
3.30–3.40 (2H, m, l,l’), 2.58 (2H, t, J = 6.9 Hz, e), 2.25–2.35 (1H, m, j), 2.15–2.25 (1H, m, j), 
1.50–1.70 (3H, m, f,i), 1.30–1.45 (2H, m, g,i), 1.10–1.25 (1H, m, g), 0.25–0.40 (1H, m, h); 13C 
NMR (100 MHz, CDCl3) δ 173.90 (k), 143.63 (d), 128.68 (b,b’), 128.39 (c,c’), 125.64 (a), 66.94 
and 66.86 (m,m’), 46.28 and 41.86 (l,l’), 36.70 (e), 31.79 (j), 31.07 (f), 30.09 (g), 26.60 (i); IR 
(neat) 2908, 2854, 1609 (C=O stretch), 1461 (N-H bend), 1434, 1240 (C-N stretch), 1114, 1064, 
957, 932, 742, 702 cm-1; HRMS (ESI) calcd. for C17H24BF3NO2 (M-Cs): 342.1852, found 
342.1852 m/z. 
 
(S)-7-phenyl-4-(trifluoroborato)heptanecarboxylic acid benzyl amide, cesium salt 
(11d). Following GP7 with -dioxaborato amide 6d (421 mg, 1.0 mmol, 1.0 equiv) affords the title 
compound (396 mg, 80%) as a white foamy solid: mp 57.5–58.5 ºC; [α]D20 = -2.9o (c 1.0, MeOH); 
19F NMR (376 MHz, MeOD) δ -131.52 (s, BF3Cs); 1H NMR (400 MHz, MeOD) δ 7.00–7.40 (10H, 
m, a,b,b’,c,c’,n,n’,o,o’,p), 4.36 (2H, s, l), 2.56 (2H, t, J = 7.7 Hz, e), 2.30 (2H, t, J = 8.1 Hz, j), 
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1.55–1.80 (4H, m, f,i), 1.40–1.55 (1H, m, g), 1.20–1.30 (1H, m, g), 0.30–0.50 (1H, m, h); 13C 
NMR (100 MHz, MeOD) δ 177.08 (k), 143.66 (d), 138.97 (m), 128.16 (b,b’), 128.14 (o,o’), 127.76 
(n,n’), 127.16 (c,c’), 126.74 (p), 124.94 (a), 42.67 (l), 36.67 (e), 36.01 (j), 31.06 (f), 30.79 (g), 
27.83 (i); IR (neat) 3408 (N-H stretch), 3294 2919, 2852, 1640 (C=O stretch), 1521, 1495, 1452 
(N-H bend), 1528, 912, 744, 697 cm-1; HRMS (ESI) calcd. for C20H24BF3NO (M-Cs): 362.1903, 
found 362.1897 m/z. 
General procedure for Suzuki-Miyaura cross-coupling reactions (GP8). 
 (S)-4,7-diphenylheptanecarboxylic acid morpholino amide ((S)-21c). An 8-mL vial was 
charged with Buchwald cataCXium® A Pd G3 precatalyst 20 (5.5 mg, 0.0075 mmol, 0.075 equiv), 
K2CO3 (42 mg, 0.3 mmol, 3.0 equiv), -trifluoroborato amide 11c (57 mg, 0.12 mmol, 1.2 equiv), 
chlorobenzene (11.3 mg, 0.1 mmol, 1.0 equiv), toluene (0.5 mL), and water (0.05 mL). The 
resultant mixture was stirred at 100 oC for 24 h. After cooling to room temperature, the organic 
layer was separated, and water (1.0 mL) was added to the aqueous layer following by extraction 
with ethyl acetate (2 x 2 mL). The combined organic extracts were dried (anhyd. Na2SO4) and 
concentrated under reduced pressure. Flash chromatography on silica gel (95:5–80:20 DCM:ethyl 
acetate) affords the tile compound (22 mg, 63%) as a yellow oil; TLC analysis Rf = 0.4 (80:20 
DCM:ethyl acetate); [α]D20 = –3.7o (c 1.0, CHCl3); Chiral HPLC analysis (Chiralpak-IC, 80:20 
hexanes:isopropanol, flowrate = 1.5 mL/min) showed peaks at 75 minutes (6.5% (R)) and 81 
minutes (93.5% (S)); 1H NMR (400 MHz, CDCl3) δ 7.05–7.35 (10H, m, a,b,b’,c,c’,o,o’,p,p’,q), 
3.50–3.65 (6H, m, l,l’,m,m’), 3.10–3.30 (2H, m, l,l’), 2.50–2.65 (3H, m, e,h), 2.05–2.15 (3H, m, 
i,j), 1.80–1.90 (1H, m, i), 1.60–1.75 (2H, m, g), 1.45–1.60 (2H, m, f); 13C NMR (100 MHz, CDCl3) 
δ 171.72 (k), 144.84 (d), 142.55 (n), 128.60 (b,b’), 128.49 (p,p’), 128.33 (c,c’), 127.79 (o,o’), 
126.42 (a), 125.74 (q), 67.01 and 66.67 (m,m’), 45.88 (l,l’), 45.61 (h), 41.95 (l,l’), 36.76 (g), 36.00 
(e), 32.08 (i), 30.97 (j), 29.42 (f); IR (neat) 2919, 2851, 1644 (C=O stretch), 1452, 1426, 1230, 
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1114, 1029, 747, 699 cm-1; HRMS (ESI) calcd. for C23H29NNaO2 (M+Na): 374.2096, found 
374.2106 m/z. 
 
(S)-4-(4-methoxyphenyl)-7-phenylheptanecarboxylic acid morpholino amide (22c). 
Following GP8 with 4-chloroanisole (14.3 mg, 0.1 mmol, 1.0 equiv) affords, after flash 
chromatography on silica gel (95:5–80:20 DCM:ethyl acetate), the title compound (19.8 mg, 52%) 
as a yellow oil; TLC analysis Rf 0.4 (80:20 DCM:ethyl acetate); [α]D20 = –7.1o (c 2.0, CHCl3); 
Chiral HPLC analysis ((S,S)-WHELK-O 1, 50:50 hexanes:isopropanol, flow rate = 1.0 mL/min) 
showed peaks at 25 minutes (6.0% (R)) and 28 minutes (94.0% (S)); 1H NMR (400 MHz, CDCl3) 
δ 7.26 (2H, t, J = 7.2 Hz, o,o’), 7.17 (1H, t, J = 7.3 Hz, a), 7.11 (2H, d, J = 7.1 Hz, c,c’), 7.06 (2H, 
d, J = 8.6 Hz, b,b’), 6.85 (2H, d, J = 8.6 Hz, p,p’), 3.81 (3H, s, r), 3.60–3.65 (2H, m, m,m’), 3.55–
3.60 (4H, m, l,l’,m,m’), 3.15–3.30 (2H, m, l,l’), 2.45–2.65 (3H, m, e,h), 2.00–2.15 (3H, m, i,j), 
1.75–1.85 (1H, m, i), 1.45–1.75 (4H, m, f,g); 13C NMR (100 MHz, CDCl3) δ 171.80 (k), 158.12 
(q), 142.60 (d), 136.77 (n), 128.61 (b,b’), 128.49 (c,c’), 128.32 (o,o’), 125.72 (a), 113.96 (p,p’), 
67.02 and 66.69 (m,m’), 55.34 (r), 45.90 (l,l’), 44.76 (h), 41.95 (l,l’), 36.93 (g), 36.01 (e), 32.25 
(i), 31.02 (j), 29.44 (f); IR (neat) 2920, 2852, 1643 (C=O stretch), 1510, 1426, 1244, 1113, 1030, 
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Compound S19 was prepared as previously reported in literature.12 To a cooled (-78 oC) 
solution of S19 (4.4 mmol, 1.3 g) in THF (15 mL) was added NaHMDS (1.1 equiv, 2M, 4.84 
mmol, 2.4 mL) dropwise. The resultant mixture was stirred at -78 oC for 1h, and cinnamyl bromide 
(2 equiv, 8.8 mmol, 1.73 g) was added dropwise. The resulting mixture was slowly warmed to 
room temp and stirred for another 5h before quenching with water. The crude reaction was 
extracted with EtOAc (3 x 30 mL). The organic extracts were combined, dried (anhyd. Na2SO4), 
and concentrated under reduced pressure. Flash chromatography on silica gel (75:25 hexanes:ethyl 
acetate) affords the tile compound S20 (1.43 g, 79%) as a white solid: 143.5–144.5 ºC; TLC 
analysis Rf = 0.4 (70:30 hexanes:ethyl acetate); [α]D20 = +121o (c 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.49 (2H, d, J = 7.3 Hz), 7.25–7.45 (10H, m), 7.15–7.25 (3H, m), 6.54 (1H, d, J = 15.8 
Hz), 6.20–6.30 (1H, m), 5.33 (1H, dd, J = 9.0 and 6.2 Hz), 4.60–4.70 (1H, m), 4.00–4.20 (2H, m), 
3.32 (1H, dd, J = 13.4 and 3.1 Hz), 3.05–3.20 (1H, m), 2.70–2.80 (2H, m); 13C NMR (100 MHz, 
CDCl3) δ 173.64, 153.11, 138.36, 137.42, 135.34, 132.76, 129.54, 129.05, 128.84, 128.77, 128.65, 
127.67, 127.44, 127.38, 127.01, 126.26, 65.88, 55.80, 48.87, 38.02, 37.96; IR (neat) 3029, 1762 
(C=O stretch), 1691 (C=O stretch), 1494, 1392, 1369, 1349, 1243, 1224, 1210, 1185, 1109, 1053, 
984, 969, 743, 716, 700, 690 cm-1; HRMS (ESI) calcd. for C27H25NNaO3 (M+Na): 434.1732, 
found 434.1738 m/z. 
To a cooled (-78 oC) solution of S20 (0.38 mmol, 156 mg) in DCM (2 mL) was added 
dropwise a solution of DIBAL-H (2 equiv, 1M, 0.76 mmol, 0.76 mL) dropwise. The resultant 
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mixture was stirred at -78 oC for 2h. After quenching with satd. NH4Cl (1 mL), the Wittig reagent 
(Ph3P=CH(COOEt), 1.2 equiv, 0.456 mmol, 160 mg) in DCM (1 mL) was added dropwise. The 
resultant mixture was stirred OVN at room temp and passed through a pad of celite and washed 
with DCM (3 x 3 mL). The filtrate was concentrated under reduced pressure to give a crude S21 
(61.7 mg, 53%) used in the next step without further purification. 
A solution of S21 (0.18 mmol, 55 mg) and Pd/C (10%, 0.1 equiv) in methanol (1 mL) was 
stirred under H2 (1 atm) for 5h. The resultant mixture was passed through a pad of celite and 
concentrated under reduced pressure to give a crude S22 (55 mg, 99%) used in the next step 
without further purification. 
Following GP1 with S22 (0.16 mmol, 50 mg) affords, after column chromatography (95:5–
80:20 DCM:ethyl acetate), the title compound (R)-21c (40.2 mg, 71%) as a yellow oil; TLC 
analysis Rf = 0.4 (80:20 DCM:ethyl acetate); [α]D20 = +3.2o (c 1.0, CHCl3); (Chiralpak-IC, 80:20 
hexanes:isopropanol, flowrate = 1.5 mL/min) showed peaks at 74 minutes (82.0% (R)) and 80 
minutes (18.0% (S)); spectroscopic data matched with (S)-21c obtained from Suzuki-Miyaura 
cross-coupling of (S)-11c. 
Other stereospecific transformations of organoboranes 
Formation of -lactone via harsh oxidation of -borylated Weinreb amide 
 
(S)-5-(3-phenylpropyl)--lactone (23). To a solution of-borylated Weinreb amide 6b 
(0.264 mmol, 99 mg) in THF (5 mL) was added aq NaOH (3M, 4 mL) and H2O2 (0.5 mL of a 30% 
soln.). The resultant mixture was stirred for 2h at room temp. Sodium metabisulfite (Na2S2O5, 3 
mL of a 10% aq soln.) was added and the resultant mixture was stirred for another 15 mins before 
acidifying with HCl (6M). The resulting mixture was extracted with DCM (3 x 10 mL). The 
combined organic extracts were dried (anhyd. Na2SO4) and concentrated under reduced pressure. 
Flash chromatography on silica gel (75:25 hexanes:ethyl acetate) affords the title compound (51 
mg, 95%) as a yellow oil; TLC analysis Rf 0.5 (75:25 hexanes:ethyl acetate); [α]D20 = -22.1o (c 
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1.04, CHCl3); literature value +21.7o (c 1.04, CHCl3) for the (R)-enantiomer;13 spectroscopic data 
matched with literature:14 1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (2H, b,b’), 7.15–7.25 (2H, 
a,c,c’), 4.45–4.60 (1H, m, h), 2.69 (2H, t, J = 6.9 Hz, e), 2.54 (2H, dd, J = 9.4 and 7.0 Hz, j), 2.25–
2.40 (1H, m, i), 1.65–1.90 (5H, m, f,g,i); 13C NMR (100 MHz, CDCl3) δ 177.33 (k), 141.78 (d), 
128.52 (b,b’,c,c’), 126.08 (a), 80.95 (h), 35.59 (e), 35.20 (g), 28.94 (j), 28.10 (i), 27.14 (f). -
lactone 23 was converting to 4-hydroxy benzyl amide 7d following GP1 to confirm the er. 
C(sp3)–C(sp2) coupling of boronic ester with thiophene using NBS15 
 
(S)-7-phenyl-4-(thiophen-2-yl)heptanecarboxylic acid morpholino amide (24c). To a 
cooled (-78 oC) of thiophene (1.2 equiv, 0.3 mmol, 24 L) in THF (1 mL) was added n-BuLi (1.2 
equiv, 1.6M, 0.3 mmol, 0.19 mL) dropwise. The resultant mixture was allowed to warm to room 
temp and stirred for 1h. The reaction mixture was cooled to –78 oC again, and a solution of -
borylated morpholino amide 6c (0.25 mmol, 100 mg) in THF (0.5 ml) was added dropwise. The 
resulting mixture was stirred at the same temperature for 1h and a solution of NBS (1.2 equiv, 0.3 
mmol, 54 mg) in THF (1 mL) was added dropwise. After 1h at –78 oC, satd. Na2S2O3 (1 mL) was 
added and the reaction mixture was allowed to warm to room temp. The reaction mixture was 
diluted with EtOAc (10 mL) and water (5 mL). The layers were separated and the aqueous layer 
was extracted with EtOAc (2 x 10 mL). The combined organic extracts were dried (anhyd. Na2SO4) 
and concentrated under reduced pressure. Flash chromatography on silica gel (95:5–80:20 
DCM:ethyl acetate) affords the title compound (75 mg, 84%) as a yellow oil; TLC analysis Rf = 
0.4 (80:20 DCM:ethyl acetate);  [α]D20 = –9.1o (c 2.0, CHCl3); Chiral HPLC analysis (Chiralcel-
OJ-H, 100% isopropanol, flow rate = 1.0 mL/min) showed peaks at 12 minutes (5.5% (R)) and 18 
minutes (94.5% (S)); 1H NMR (400 MHz, CDCl3) δ 7.25–7.30 (2H, m, c,c’), 7.10–7.20 (4H, m, 
a,b,b’,r), 6.94 (1H, dd, J = 4.9 and 3.5 Hz, q), 6.79 (1H, d, J = 3.0, p), 3.55–3.70 (6H, m, l,l’,m,m’), 
3.25–3.35 (2H, m, l,l’), 2.90–3.00 (1H, m, h), 2.55–2.65 (2H, m, e), 2.10–2.25 (3H, m, i,j), 1.55–
1.85 (5H, m, f,g,i); 13C NMR (100 MHz, CDCl3) δ 171.51 (k), 149.02 (o), 142.43 (d), 128.50 
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(b,b’), 128.37 ( c,c’), 126.65 (q), 125.79 (a), 124.28 (p), 123.18 (r), 67.02 and 66.71 (m,m’), 45.92 
and 41.99 (l,l’), 40.93 (h), 37.89 (g), 35.86 (e), 33.24 (i), 30.78 (j), 29.28 (f); IR (neat) 2920, 2853, 
1642 (C=O stretch), 1452, 1429, 1229, 1113, 697 cm-1; HRMS (ESI) calcd. for C21H27NNaO2S 
(M+Na): 380.1660, found 380.1678 m/z. 
General procedure for BCl3-assisted C–B to C–N bond formation (GP9)16 
 
(S)-4-(benzylamino)-7-phenylheptanecarboxylic acid morpholino amide (25c). To a 
solution of BCl3 (5 equiv, 1M, 0.5 mmol) in DCM was added dropwise at room temp a solution of 
-borylated morpholino amide 6c (0.1 mmol, 40 mg) in DCM. After a 4h stir, the reaction mixture 
was carefully reduced under vacuum at room temp. It was then taken up in DCM (0.5 mL) and a 
solution of benzyl azide (3 equiv, 0.3 mmol, 40 mg) in DCM (0.2 mL) was added. The resultant 
mixture was stirred at room temp overnight and quenched with NaOH (2M). After extractions with 
DCM (3 x 5 mL), the combined organic extracts were dried (anhyd. Na2SO4) and concentrated 
under reduced pressure. Flash chromatography on silica gel (20:80-0:100 hexanes:acetone) affords 
the title compound (24.7 mg, 65%) as a yellow oil; TLC analysis Rf 0.2 (5:95 methanol:ethyl 
acetate); [α]D20 = +7.5o (c 1.5, CHCl3); Chiral HPLC analysis (Chiralcel-OJ-H, 90:10 
hexanes:isopropanol, flow rate = 1.5 mL/min) showed peaks at 18 minutes (94.0% (S)) and 20 
minutes (6.0% (R)); 1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (7H, m, c,c’,p,p’,q,q’,r), 7.15–7.25 
(3H, a,b,b’), 3.70–3.80 (2H, m, n), 3.55–3.70 (6H, m, l,l’,m,m’), 3.35–3.50 (2H, m, l,l’), 2.60–2.70 
(3H, m, e,h), 2.36 (2H, t, J = 7.5 Hz, j), 1.80–1.90 (1H, m, i), 1.60–1.80 (1H, m, f,i), 1.45–1.60 
(2H, m, g); 13C NMR (100 MHz, CDCl3) δ 172.10 (k), 142.40 (d), 140.76 (o), 128.55 (b,b’), 128.51 
(q,q’), 128.43 (c,c’), 128.28 (p,p’), 127.06 (r), 125.89 (a), 67.04 and 66.76 (m,m’), 56.17 (h), 50.99 
(n), 46.03 and 42.03 (l,l’), 36.07 (e), 33.47 (g), 29.02 (j), 28.99 (i), 27.64 (f); IR (neat) 2934, 2854, 
1640 (C=O stretch), 1452, 1430, 1114, 746, 698 cm-1; HRMS (ESI) calcd. for C24H32N2NaO2 
(M+Na): 403.2361, found 403.2363 m/z. 
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Formation of -lactam via C–B to C–N formation followed by acidic removal of morpholino 
amide 
 
(S)-N-phenyl-3-(phenylpropyl)--lactam (26). Following GP9 with phenyl azide (3 
equiv, 0.3 mmol, 36 mg) affords the corresponding amine, which was then taken up in HCl (6M, 
1 mL). After 6h reflux, the reaction mixture was cooled to room temp and extracted with DCM (3 
x 2 mL). The combined organic extracts were dried (anhyd. Na2SO4) and concentrated under 
reduced pressure. Flash chromatography on silica gel (80:20-40:60 hexanes:ethyl acetate) affords 
the title compound (19 mg, 68%) as a yellow liquid; TLC analysis Rf 0.4 (40:60 hexanes:ethyl 
acetate); [α]D20 = +30.5o (c 0.74, CHCl3); Chiral HPLC analysis ((S,S)-WHELK-O 1, 100% 
isopropanol, flow rate = 1.0 mL/min) showed peaks at 9 minutes (5.5% (R)) and 17 minutes (94.5% 
(S)); 1H NMR (400 MHz, CDCl3) δ 7.35–7.45 (4H, m, m,m’,n,n’), 7.20–7.30 (4H, m, a,b,b’,o), 
7.12 (2H, d, J = 7.2 Hz, c.c’), 4.30–4.30 (1H, m, h), 2.50–2.70 (4H, m, e,j), 2.30–2.40 (1H, m, i), 
1.80–1.90 (1H, m, i), 1.55–1.80 (3H, m, f,g), 1.40–1.50 (1H, m, g); 13C NMR (100 MHz, CDCl3) 
δ 174.46 (k), 141.83 (d), 137.71 (l), 129.15 (n,n’), 128.50 (b,b’), 128.36 (c,c’), 126.06 (o), 126.00 
(a), 124.32 (m,m’), 59.78 (h), 35.71 (e), 33.08 (g), 31.41 (j), 26.50 (f), 24.07 (i); IR (neat) 2933, 
1690 (C=O stretch), 1596, 1496, 1388, 1292, 1220, 752, 693 cm-1; HRMS (ESI) calcd. for 
C19H21NNaO (M+Na): 302.1521, found 302.1534 m/z. 
Formation of 1,4-aminoalcohol via oxidation of C–B bond followed by amide reduction with 
LiAlH4 
 
(S)-1-(benzylamino)-7-phenyl-4-heptanol (27d). To a solution of-borylated benzyl 
amide 6d (0.3 mmol, 127 mg) in THF (5 mL) was added aq NaOH (3M, 6 mL) and H2O2 (0.8 mL 
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of a 30% soln.). The resultant mixture was stirred for 1h at room temp. After extraction with DCM 
and concentration under reduced pressure, without further purification, the obtained residue (crude 
7d) was taken up with THF (1.5 mL). To the cooled (0 oC) resultant mixture was added LiAlH4 (2 
equiv, 0.6 mmol, 23 mg). The reaction mixture was refluxed overnight. After cooling to room 
temp, the resulting mixture was quenched with KOH (5M, 0.05 mL) and water (0.05 mL) followed 
by 30-min stir. The reaction mixture was then filtered through a pad of celite and washed with 
EtOAc (3 x 2 mL). The filtrate was concentrated under reduced pressure. Flash chromatography 
on silica gel (50:50-0:100 hexanes:acetone) affords the title compound (84 mg, 94%) as a light 
yellow solid: m.p. 48.5–49.0 ºC; TLC analysis Rf 0.2 (5:95 methanol:ethyl acetate); [α]D20 = +20.4o 
(c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.20–7.40 (10H, a,b,b’,c,c’,n,n’,o,o’,p), 3.80 (2H, 
d, J = 1.9 Hz, e), 3.40–3.70 (2H, m, i,OH), 2.75–2.85 (1H, m, f), 2.67 (2H, t, J = 7.7 Hz, l), 2.55–
2.65 (1H, m, f), 1.65–1.90 (4H, m, h,k), 1.40–1.60 (4H, m, g,j); 13C NMR (100 MHz, CDCl3) δ 
142.85 (m), 139.41 (d), 128.69 (b,b’), 128.58 (o,o’), 128.45 (n,n’), 127.35 (c,c’), 127.37 (a), 125.72 
(p), 71.33 (i), 53.98 (e), 49.57 (f), 37.51 (j), 37.19 (h), 36.20 (l), 27.97 (k), 27.41 (g); IR (neat) 
3267 (N-H stretch, O-H stretch), 3084, 3026, 2868, 2827, 2813, 1495, 1451, 1363 (C-N stretch), 
1346, 1118, 858, 734, 691 cm-1; HRMS (ESI) calcd. for C20H27NNaO (M+Na): 320.1990, found 
320.1990 m/z. 
Vinylation of boronic ester using vinylmagnesium bromide17 
 
(S)-7-phenyl-4-vinylheptanecarboxylic acid benzyl amide (28d). To ad solution of -
borylated benzyl amide 6d (0.15 mmol, 63 mg) in THF (1.5 mL) was added vinylmagnesium 
bromide (4 equiv, 1M, 0.6 mmol, 0.6 mL) dropwise. The resultant mixture was stirred as room 
temp for 30 mins. To the above solution at-78 oC was added iodine (4 equiv, 0.6 mmol, 152 mg) 
in methanol (2.0 mL) dropwise. The reaction mixture was allowed to stir 30 mins at the same temp 
followed by dropwise addition of a solution of NaOMe (8 equiv, 1.2 mmol, 65 mg) in methanol 
(2.5 mL). After warming to room temp, the resultant mixture was stirred for another 1.5h. It was 
then diluted with pentane (20 mL) and wash sequentially with 10% aqueous soln. of Na2S2O3 (5 
mL) and water (5 mL). The organic layer was separated and the aqueous layer was washed with 
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pentane (2 x 10 mL). The combined organic layers were dried (anhyd. Na2SO4) and concentrated 
under reduced pressure. Flash chromatography on silica gel (80:20-60:40 hexanes:ethyl acetate) 
affords the title compound (45 mg, 93%) as a colorless oil; TLC analysis Rf 0.5 (50:50 
hexanes:ethyl acetate); [α]D20 = –4.1o (c 2.0, CHCl3); Chiral HPLC analysis (Chiralcel-OJ-H, 90:10 
hexanes:isopropanol, flow rate = 1.0 mL/min) showed peaks at 18 minutes (4.0% (R)) and 22 
minutes (96.0% (S)); 1H NMR (400 MHz, CDCl3) δ 7.35–7.40 (2H, m, b,b’), 7.25–7.35 (5H, a, 
n,n’,o,o’), 7.15–7.25 (3H. c,c’,p), 5.76 (1H, br s, NH), 5.50 (1H, dt, J = 17.0 and 9.6 Hz, q), 5.02 
(1H, dd, J = 10.1 and 1.6 Hz, r), 4.96 (1H, dd, J = 17.1 and 1.5 Hz, r), 4.45 (2H, dd, J = 5.1 and 
4.0 Hz, e), 2.50–2.70 (2H, m, l), 2.20–2.30 (1H, m, g), 2.10–2.20 (1H, m, g), 1.95–2.10 (1H, m, 
i), 1.80–1.90 (1H, m, k), 1.50–1.75 (3H, m, h,k), 1.40–1.50 (1H, m, j), 1.30–1.40 (1H, m, j); 13C 
NMR (100 MHz, CDCl3) δ 172.96 (f), 142.72 (q), 142.36 (m), 138.54 (d), 128.83 (o,o’), 128.53 
(b,b’), 128.38 (n,n’), 127.98 (c,c’) 127.63 (a), 125.76 (p), 115.58 (r), 43.96 (i), 43.71 (e), 36.03 (l), 
34.77 (j), 34.59 (g), 30.69 (k), 29.13 (h); IR (neat) 3275 (N-H stretch), 3063, 3027, 2925, 2856, 
1641 (C=O stretch), 1541, 1495, 1453, 911, 745, 696 cm-1; HRMS (ESI) calcd. for C22H27NNaO 
(M+Na): 344.1990, found 344.1996 m/z. 
 
Determination of absolute configurations (Detailed procedures described above.) 
-Borylated carbonyl derivatives 6b-d were obtained by CAHB of 5b-d using (R)-L1 as 
described above. Treatment of 6b with NaOH/ H2O2 generated an enantiomer of a known lactone 
(R)-23. The opposite sign of optical rotation showed that CAHB products are (S)-enantiomers. To 
further confirm the assignment, (S)-23 and (S)-7c were converted to (S)-7d resulting in the same 
order of elution in HPLC (traces shown below, vide infra). 
To determine the Suzuki-Miyaura product configuration, authentic (R)-21c was prepared 
via Evan’s chiral auxiliary enolate allylation, in situ half reduction to aldehyde followed by Wittig 
reaction, Pd/C hydrogenation and morpholine transamidation. Though S20 is not known in 
literature, allylation18,19 and benzylation12 of S19 were reported in the same sense of 
diastereoselectivity. HPLC traces of authentic (R)-21c and 21c obtained from Suzuki-Miyaura 
cross-coupling of 6c (after converting to trifluoroborate 11c) showed that they are enantiomers 
indicating the Suzuki product was (S)-enantiomers. Starting from (S)-6c to obtain (S)-21c leads to 

































D20 = -22.1 (c 1.04)
(R)-23
D20 = +21.7 (c 1.04)













































 The two figures below are the 1H NMR regions of NH and methyl groups of Mosher ester 
S17, prepared from 7n (obtained from CAHB of 5n with (R)-L1, vide supra) and (S)-Mosher acid, 
respectively. From the figures, the major NH is more downfield, whereas, the major methyl group 
is more upfield. According to Feng Shao’s20 protocol for determination of absolute configuration 
using Mosher ester analysis, the NH is on the same side of the methoxy group and the methyl 
group is on the opposite side of the methoxy group resulting in S,S-configuration of S17. The 
method might not be reliable for determining absolute configuration of S17 by itself since both 
NH and methyl groups are quite far away from the Mosher ester chiral center. However, the result 
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m.p. 106.0–107.0 oC 
TLC analysis Rf  0.65 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.54 (2H, d, J = 7.8 Hz, m,m’), 7.48 (1H, br s, NH), 7.25–7.40 (4H, m, b,b’,n,n’), 7.15–
7.25 (3H, m, c,c’,a), 7.13 (1H, t, J = 7.4 Hz, o), 5.40–5.70 (2H, m, g,h), 2.70 (2H, t, J = 
7.4 Hz, e), 2.25–2.50 (6H, m, f,i,j) 
13C NMR (100 MHz, CDCl3) 
δ 171.03 (k), 142.00 (d), 138.06 (l), 131.30 (h), 129.10 (g), 129.05 (n,n’), 128.61 (b,b’), 
128.40 (o), 125.92 (c,c’), 124.36 (a), 120.07 (m,m’), 37.65 (e), 36.01 (j), 34.44 (f), 28.60 
(i) 
IR (neat) 3305 (N-H stretch), 3265, 2193, 1664 (C=O stretch), 1603, 1546, 1439, 972, 757, 693 cm-1 
















TLC analysis Rf  0.5 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (2H, m, b,b’), 7.15–7.25 (3H, m, a,c,c’), 5.45–5.65 (2H, m, g,h), 3.69 (3H, s, m), 3.20 (3H, s, l),  2.69 (2H, t, J = 7.4 Hz, e), 2.49 (2H, m, j), 2.20–2.40 (4H, m, f,i) 
13C NMR (100 MHz, CDCl3) δ 174.14 (k), 142.16 (d), 130.50 (h), 129.63 (g), 128.59 (b,b’), 128.35 (c,c’), 125.84 (a), 61.33 (m), 36.10 (e), 34.50 (f), 32.30 (l), 32.01 (j), 27.65 (i) 
IR (neat) IR (neat) 2934 (C-H sp
3 stretch), 1661 (C=O stretch), 1452, 1413, 1383 (C-N stretch), 
969, 698 cm-1 














TLC analysis Rf  0.4 (40:60 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.35 (2H, m, b,b’), 7.15–7.25 (3H, m, a,c,c’), 5.40–5.60 (2H, m, g,h), 3.55–3.70 
(6H, m, l,l’,m,m’), 3.35–3.50 (2H, m, l,l’),  2.68 (2H, t, J = 7.5 Hz, e), 2.20–2.40 (6H, 
m, f,i,j) 
13C NMR (100 MHz, CDCl3) δ 171.23 (k), 142.05 (d), 131.68 (h), 129.47 (g), 128.59 (b,b’), 128.36 (c,c’), 125.87 (a), 67.05 and 66.76 (m,m’), 46.08 and 42.01 (l,l’), 36.04 (e), 34.46 (f), 33.13 (j), 28.28 (i) 
IR (neat) IR (neat) 2914 (C-H sp3 stretch), 2852, 1642 (C=O stretch), 1428, 1113, 968, 699 cm-1 














m.p. 65.5–66.5 oC 
TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.15–7.40 (10H, m, a,b,b’,c,c’,n,n’,o,o’,p), 5.89 (1H, br s, NH), 5.40–5.60 (2H, m, g,h), 4.44 (2H, d, J = 5.7 Hz, l), 2.67 (2H, t, J = 7.3 Hz, e), 2.20–2.40 (6H, m, f,i,j) 
13C NMR (100 MHz, CDCl3) 
δ 172.45 (k), 142.04 (d), 138.55 (m), 131.03 (h), 129.23 (g), 128.80 (b,b’), 128.61 (o,o’), 
128.38 (c,c’), 127.93 (n,n’), 127.60 (p), 125.89 (a), 43.66 (l), 36.71 (j), 35.96 (e), 34.40 
(f), 28.73 (i) 
IR (neat) 3285 (N-H stretch), 3028, 2915, 1635 (C=O stretch), 1537 (N-H bend), 1452, 1220, 965, 740, 694 cm-1 














TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.15–7.40 (10H, m, a,b,b’,c,c’,n,n’,o,o’,p), 6.03 (1H, br s, NH), 5.45–5.55 (1H, m, h), 
5.35–5.45 (1H, m, g), 4.41 (2H, d, J = 5.7 Hz, l), 2.69 (2H, t, J = 7.8 Hz, e), 2.41 (2H, q, 
J = 7.4 Hz, f), 2.33 (2H, q, J = 7.4 Hz, i), 2.08 (2H, t, J = 8.6 Hz, j) 
13C NMR (100 MHz, CDCl3) 
δ 172.53 (k), 142.10 (d), 138.55 (m), 130.29 (h), 128.81 (b,b’), 128.78 (o,o’), 128.41 
(g,c,c’), 127.92 (n,n’), 127.57 (p), 125.92 (a), 43.65 (l), 36.53 (j), 35.91 (e), 29.29 (f), 
23.61 (i) 
IR (neat) 3285 (N-H stretch), 3026, 2922, 1642 (C=O stretch), 1543 (N-H bend), 1495, 1453, 728, 695 cm-1 














m.p. 60.5–61.5 oC 
TLC analysis Rf  0.35 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.40 (6H, m, a,b,b’,c,c’,p), 6.28 (1H, dd, J = 3.0 Hz, 1.9 Hz, o), 5.98 (1H, dd, J 
= 3.1 Hz, 0.6 Hz, n), 5.90 (1H, br s, NH), 5.40–5.60 (2H, m, i,j), 4.44 (2H, d, J = 5.7 Hz, 
e), 2.67 (2H, t, J = 7.4 Hz, l), 2.20–2.40 (6H, m, g,h,k) 
13C NMR (100 MHz, CDCl3) 
δ 172.40 (f), 155.78 (m), 140.89 (p), 138.51 (d), 130.53 (i), 129.50 (j), 128.80 (b,b’), 
127.92 (c,c’), 127.60 (a), 110.17 (o), 105.03 (n), 43.66 (e), 36.64 (g), 31.02 (k), 28.68 
(h), 28.07 (l) 
IR (neat) 3293 (N-H stretch), 2916, 1632 (C=O stretch), 1538 (N-H bend), 1506, 1453, 729, 695 cm-1 














m.p. 62.0–63.0 oC 
TLC analysis Rf  0.35 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.40 (2H, m, b,b’), 7.25–7.30 (3H, m, a, c,c’), 7.12 (1H, dd, J = 5.2 Hz, 0.8 Hz, 
p), 6.93 (1H, dd, J = 4.9 Hz, 3.5 Hz, o), 6.79 (1H, d, J = 2.6 Hz, n), 6.20 (1H, br s, NH), 
5.40–5.60 (2H, m, i,j), 4.42 (2H, d, J = 5.7 Hz, e), 2.87 (2H, t, J = 7.4 Hz, l), 2.30–2.40 
(4H, m, h,k), 2.26 (2H, t, J = 7.1 Hz, g) 
13C NMR (100 MHz, CDCl3) 
δ 172.55 (f), 144.86 (m), 138.62 (d), 130.32 (i), 129.85 (j), 128.78 (b,b’), 127.89 (c,c’), 
127.56 (a), 126.81 (o), 124.34 (p), 123.10 (n), 43.61 (e), 36.56 (g), 34.65 (k), 30.00 (h), 
28.75 (l) 
IR (neat) 3291 (N-H stretch), 3030, 2915, 1629 (C=O stretch), 1531 (N-H bend), 1453, 968, 746, 693 cm-1 
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TLC analysis Rf  0.5 (40:60 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.35–7.40 (2H, m, b,b’), 7.25–7.35 (3H, m, a,c,c’), 5.99 (1H, br s, NH), 5.77 (2H, s, 
o,o’), 5.40–5.50 (2H, m, i,j), 4.44 (2H, d, J = 5.8 Hz, e), 3.76 (2H, t, J = 7.4 Hz, l),  2.35–
2.45 (2H, m, h), 2.25–2.35 (2H, m, k), 2.25 (2H, t, J = 7.0 Hz, g, overlapping with n,n’), 
2.23 (6H, s, n,n’) 
13C NMR (100 MHz, CDCl3) δ 172.35 (f), 138.63 (d), 131.62 (i), 128.79 (b,b’,m,m’), 127.92 (c,c’), 127.58 (a), 127.40 (j), 105.12 (o,o’), 43.63 (e), 43.48 (l), 36.51 (g), 34.18 (k), 28.80 (h), 12.73 (n,n’) 
IR (neat) 3283 (N-H stretch), 2914, 1643 (C=O stretch), 1539 (N-H bend), 1453, 1407, 970, 743, 697 cm-1 














m.p. 45.0–45.5 oC 
TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.15–7.40 (5H, m, a,b,b’,c,c’), 6.08 (1H, br s, NH), 5.30–5.50 (2H, m, i,j), 4.42 (2H, d, J = 5.7 Hz, e), 2.15–2.40 (5H, m, g,h,k), 0.95 (6H, d, J = 6.7 Hz, l,l’) 
13C NMR (100 MHz, CDCl3) δ 172.61 (f), 139.20 (d), 138.55 (j), 128.76 (b,b’), 127.88 (c,c’), 127.53 (i), 125.35 (a), 43.61 (e), 36.73 (g), 31.04 (k), 28.69 (h), 22.60 (l,l’) 
IR (neat) 3292 (N-H stretch), 2959, 2928, 2870, 1633 (C=O stretch), 1534 (N-H bend), 1454, 1407, 968, 746, 694 cm-1 














TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.40 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’),  6.09 (1H, br s, NH), 5.35–5.55 
(2H, m, i,j), 4.42 (2H, d, J = 5.6 Hz, e), 2.30–2.40 (2H, m, h), 2.25–2.30 (2H, m, g) 1.87 
(2H, t, J = 6.6 Hz, k), 1.50–1.65 (1H, m, l), 0.87 (6H, d, J = 6.6 Hz, m,m’) 
13C NMR (100 MHz, CDCl3) 172.57 (f), 138.55 (d), 130.78 (i), 129.52 (j), 128.76 (b,b’), 127.89 (c,c’), 127.53 (a), 43.63 (e), 42.00 (k), 36.75 (g), 28.79 (h), 28.45 (l), 22.37 (m,m’) 
IR (neat) 3286 (N-H stretch), 2953, 2923, 2868, 1642 (C=O stretch), 1544 (N-H bend), 1454, 967, 696 cm-1 














[α]D20 +6.2o (c 2.0, CHCl3) 
TLC analysis Rf  0.4 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.22 (1H, br s, NH), 5.35–5.50 (2H, 
m, i,j), 5.11 (1H, tt, J = 7.2 Hz, 1.3 Hz, p),  4.40 (2H, d, J = 5.8 Hz, e), 2.30–2.40 (2H, 
m, h), 2.25–2.30 (2H, m, g), 1.90–2.05 (3H, m, k,o), 1.75–1.85 (1H, m, k), 1.70 (3H, s, 
r), 1.62 (3H, s, s),1.40–1.50 (1H, m, l), 1.25–1.40 (1H, m, n), 1.10–1.20 (1H, m, n), 0.86 
(3H, d, J = 6.6 Hz, m) 
13C NMR (100 MHz, CDCl3) 
δ 172.62 (f), 138.58 (d), 131.17 (q), 130.47 (i), 129.69 (j), 128.73 (xwinb,b’), 127.86 
(c,c’), 127.49 (a), 124.98 (p), 43.60 (e), 40.05 (k), 36.77 (n), 36.71 (g), 32.77 (l), 28.83 
(h), 25.85 (r), 25.70 (o), 19.46 (m), 17.77 (s) 
IR (neat) 3277 (N-H stretch), 2959, 2911, 1643 (C=O stretch), 1545 (N-H bend), 1453, 968, 696 cm-1 














TLC analysis Rf  0.5 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.20–7.40 (5H, m, a,b,b’,c,c’), 6.14 (1H, br s, NH), 5.40–5.55 (2H, m, i,j), 4.41 (2H, 
d, J = 5.7 Hz, e), 3.67 (2H, t, J = 6.8 Hz, l), 2.20–2.40 (6H, m, g,h,k), 1.00–1.15 (21H, 
m, m,m’,m’’,n,n’,n’’) 
13C NMR (100 MHz, CDCl3) δ 172.55 (f), 138.55 (d), 130.49 (i), 128.75 (b,b’), 128.29 (j), 127.84 (c,c’), 127.51 (a), 63.44 (l), 43.61 (e), 36.52 (k), 36.50 (g), 28.85 (h), 18.14 (n,n’,n’’), 12.11 (m,m’,m’’) 
IR (neat) 3283 (N-H stretch), 2942, 2864, 1644 (C=O stretch), 1545 (N-H bend), 1455, 1100, 881, 679 cm-1 














[α]D20 +19.2o (c 2.0, CHCl3) 
TLC analysis Rf  0.25 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.11 (1H, br s, NH), 5.40–5.60 (2H, 
m, i,j), 4.40 (2H, d, J = 5.7 Hz, e), 4.00–4.10 (1H, m, l),  3.97 (1H, dd, J = 8.0 Hz, 6.0 
Hz, m), 3.52 (1H, dd, J = 7.9 Hz, 7.0 Hz, m), 2.30–2.40 (3H, m, h,k), 2.25–2.30 (2H, m, 
g), 2.15–2.25 (1H, m, k), 1.40 (3H, s, o), 1.33 (3H, s, o’) 
13C NMR (100 MHz, CDCl3) 
δ 172.32 (f), 138.53 (d), 131.82 (i), 128.76 (b,b’), 127.86 (c,c’), 127.54 (a), 126.52 (j), 
109.00 (n), 75.53 (l), 68.92 (m), 43.60 (e), 36.92 (k), 36.37 (g), 28.70 (h), 27.01 and 
25.74 (o,o’) 
IR (neat) 3291 (N-H stretch), 2984, 2933, 1643 (C=O stretch), 1541 (N-H bend), 1454, 1369, 1213, 1154, 1058, 969, 697 cm-1 














[α]D20 +25.1o (c 2.0, CHCl3) 
TLC analysis Rf  0.25 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.02 (1H, br s, NH), 5.79 (1H, td, 
J = 15.3 Hz, 6.5 Hz, i), 5.49 (1H, dd, J = 15.4 Hz, 7.7 Hz, j), 4.35–4.50 (1H, m, k), 4.41 
(2H, d, J = 5.7 Hz, e), 4.03 (1H, dd, J = 8.1 Hz, 6.1 Hz, l), 3.52 (1H, dd, J = 8.0 Hz, 8.0 
Hz, l),  2.35–2.45 (2H, m, h), 2.25–2.35 (2H, m, g), 1.41 (3H, s, n), 1.38 (3H, s, n’) 
13C NMR (100 MHz, CDCl3) δ 171.96 (f), 138.41 (d), 133.72 (i), 128.80 (b,b’), 128.77 (j), 127.91 (c,c’), 127.62 (a), 109.25 (m), 69.48 (k), 43.68 (e), 35.84 (g), 28.23 (h), 26.83 and 26.01 (n,n’) 
IR (neat) 3294 (N-H stretch), 2985, 2933, 2872, 1644 (C=O stretch), 1541 (N-H bend), 1454, 1369, 1244, 1213, 1155, 1057, 1028, 967, 859, 732, 697 cm-1 














m.p. 58.5–59.5 oC 
TLC analysis Rf  0.40 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.30–7.35 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.20 (1H, br s, NH), 5.25–5.55 (2H, m, i,j), 2.30–2.35 (2H, m, h), 2.20–2.30 (2H, m, g), 1.64 (3H, d, J = 5.8 Hz, k) 
13C NMR (100 MHz, CDCl3) δ 172.64 (f), 138.59 (d), 129.64 (i), 128.74 (b,b’), 127.85 (c,c’), 127.49 (a), 126.43 (j), 43.58 (e), 36.60 (g), 28.75 (h), 18.00 (k) 
IR (neat) 3289 (N-H stretch), 2918, 1633 (C=O stretch), 1548 (N-H bend), 1493, 1452, 1234, 964, 747, 697 cm-1 














m.p. 67.0–68.0 oC 
TLC analysis Rf  0.40 (60:40 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.40 (7H, m, b,b’,o,o’,p,p’,q), 7.15–7.25 (3H, m, a,c,c’), 5.68 (1H, br s, NH), 
5.30–5.50 (2H, m, g,h), 4.44 (2H, d, J = 5.7 Hz, m), 2.69 (2H, t, J = 7.4 Hz, e), 2.34 (2H, 
q, J = 6.6 Hz, f), 2.11 (2H, t, J = 7.4 Hz, k), 2.04 (2H, q, J = 6.6 Hz, i), 1.65–1.80 (2H, 
m, j) 
13C NMR (100 MHz, CDCl3) 
δ 172.92 (l), 142.08 (d), 138.54 (n), 130.66 (g), 130.17 (h), 128.83 (b,b’), 128.64 (p,p’), 
128.37 (c,c’), 128.00 (o,o’), 127.64 (q), 125.84 (a), 43.70 (m), 36.95 (e), 35.80 (k), 34.19 
(f), 31.95 (i), 25.37 (j) 
IR (neat) 3290 (N-H stretch), 2924, 2848, 1629 (C=O stretch), 1550 (N-H bend), 1494, 1452, 726, 693 cm-1 














TLC analysis Rf  0.4 (90:10 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, m, b,b’), 7.30–7.35 (3H, m, a,c,c’), 5.45–5.60 (2H, m, g,h), 4.18 (2H, 
q, J = 7.1 Hz,, l), 2.72 (2H, t, J = 7.3 Hz, e), 2.30–2.40 (6H, m, f,i,j), 1.30 (3H, t, J = 7.1 
Hz, m) 
13C NMR (100 MHz, CDCl3) δ 173.27 (k), 142.07 (d), 130.85 (h), 128.96 (g), 128.59 (b,b’), 128.39 (c,c’), 125.90 (a), 60.35 (l), 36.09 (e), 34.49 (j), 34.44 (f), 28.04 (i), 14.42 (m) 
IR (neat) 2980, 2925, 1732 (C=O stretch), 1453, 1371, 1247, 1175, 1032, 968, 745, 698 cm-1 














[α]D20  +5.1o (c 2.0, CHCl3) 
TLC analysis Rf 0.4 (60:40 hexanes:ethyl acetate) 
11B NMR (128 MHz, CDCl3) δ 33.87 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.30  (2H, m, b,b’), 7.15–7.25 (3H, m, a,c,c’), 3.67 (3H, s, o), 3.18 (3H, s, n), 
2.62 (2H, d, J = 7.6 Hz, e), 2.30–2.60 (2H, m, l), 1.40–1.80 (6H, m, f,g,k), 1.26 (12H, s, 
j,j’,j’’,j’’’), 1.00–1.15 (1H, m, h) 
13C NMR (100 MHz, CDCl3) δ 174.93 (m), 142.89 (d), 128.50 (b,b’), 128.31 (c,c’), 125.63 (a), 83.09 (i,i’), 61.29 (o), 36.30 (e), 32.28 (n), 31.71 (l), 31.01 (f), 31.00 (g), 26.30 (k), 24.97 and 24.93 (j,j’,j’’,j’’’)
IR (neat) 2976, 2930, 2857, 1663 (C=O stretch), 1380 (C-N stretch), 1314, 1142 , 699 cm-1 

















[α]D20  +0.3o (c 2.0, CHCl3) 
TLC analysis δ 34.34 
11B NMR (128 MHz, CDCl3) Rf 0.4 (40:60 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.35  (2H, m, b,b’), 7.10–7.25 (3H, m, a,c,c’), 3.55–3.70 (6H, m, n,n’,o,o’), 3.40–
3.50 (2H, m, n,n’), 2.61 (2H, d, J = 7.2 Hz, e), 2.25–2.40 (2H, m, l), 1.40–1.80 (6H, m, 
f,g,k), 1.24 (12H, s, j,j’,j’’,j’’’), 1.00–1.10 (1H, m, h) 
13C NMR (100 MHz, CDCl3) 
δ 172.11 (m), 144.78 (d), 128.49 (b,b’), 128.32 (c,c’), 125.67 (a), 83.17 (i,i’), 67.06 and 
66.86 (o,o’), 46.19 and 41.95 (n.n’), 36.25 (e), 33.08 (l), 30.92 (f), 30.89 (g), 26.99 (k), 
25.00 and 24.94 (j,j’,j’’,j’’’) 
IR (neat) 2974, 2924, 2854, 1644 (C=O stretch), 1425 1380 (C-N stretch), 1142, 1114, 699 cm-1 
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[α]D20  +2.4o (c 2.0, CHCl3) 
TLC analysis Rf 0.3 (60:40 hexanes:ethyl acetate) 
11B NMR (128 MHz, CDCl3) δ 34.51 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.40  (2H, m, q,q’), 7.25–7.30 (5H, m, b,b’,c,c’,r), 7.15–7.25 (3H, m, a,p,p’), 6.00 
(1H, br s, NH), 4.44 (2H, d, J = 5.8 Hz, n), 2.61 (2H, t, J = 7.6 Hz, e), 2.15–2.30 (2H, m, 
l), 1.70–1.85 (2H, m, k), 1.60–1.70 (2H, m, f), 1.50–1.60 (1H, m, g), 1.40–1.50 (1H, m, 
g), 1.23 (12H, s, j,j’,j’’,j’’’), 1.00–1.10 (1H, m, h) 
13C NMR (100 MHz, CDCl3) 
δ 173.19 (m), 142.82 (d), 138.60 (o), 128.78 (q,q’), 128.51 (b,b’), 128.34 (c,c’), 128.00 
(p,p’), 127.55 (r), 125.69 (a), 83.25 (i,i’), 43.72 (n), 36.50 (l), 36.26 (e), 30.98 (f), 30.94 
(g), 27.49 (k), 24.95 (j,j’,j’’,j’’’) 
IR (neat) 3285 (N-H stretch), 2976, 2926, 2856, 1644 (C=O stretch), 1541 (N-H bend), 1454, 1379 (C-N stretch), 1315, 1141, 747, 697 cm-1 


















[α]D20  –12.5o (c 2.0, CHCl3) 
TLC analysis Rf  0.5 (0:100 hexanes:ethyl acetate) 
HPLC analysis 
er of 7b was determined by using harsh oxidation (NaOH/H2O2) instead of NaBO3-
tetrahydrate to form lactone 23 followed by transamidation with benzyl amine to 
generate 7d (procedures described vide infra): Chiral HPLC analysis (Chiralpak-IC, 
60:40 hexanes:isopropanol, flow rate = 1.3 mL/min) showed peaks at 26 minutes (4.0% 
(R)) and 30 minutes (96.0% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.30 (2H, m, b,b’), 7.15–7.25 (3H, m, a,c,c’), 3.70 (3H, s, m), 3.60–3.70 (1H, m, 
h, overlapping with m), 3.20 (3H, s, l),  2.74 (1H, br s, OH), 2.66 (2H, t, J = 7.6 Hz, e), 
2.50–2.70 (2H, m, j, overlapping with e), 1.80–1.90 (2H, m, f,i), 1.65–1.75 (2H, m, f,i), 
1.45–1.65 (2H, m, g) 
13C NMR (100 MHz, CDCl3) δ 175.19 (k), 142.55 (d), 128.54 (b,b’), 128.38 (c,c’), 125.78 (a), 71.45 (h), 61.35 (m), 37.36 (g), 35.99 (e), 32.37 (l), 31.74 (i), 28.63 (j), 27.62 (f) 
IR (neat) 3430 (O-H stretch), 2933, 2858, 1639 (C=O stretch), 1452, 1416, 1386, 1177, 994, 748, 699 cm-1 
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[α]D20  –5.1o (c 2.0, CHCl3) 
TLC analysis Rf  0.7 (20:80 hexanes:acetone) 
HPLC analysis 
er of 7c was determined by boric acid-catalyzed transamidation with benzyl amine to 
form 7d: Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flow rate = 
1.3 mL/min) showed peaks at 28 minutes (5.5 0% (R)) and 31 minutes (94.5% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.30 (2H, m, b,b’), 7.15–7.20 (3H, m, a,c,c’), 3.55–3.70 (7H, m, h,l,l’,m,m’), 
3.40–3.50 (2H, m, l,l’),  2.64 (2H, t, J = 7.6 Hz, e), 2.46 (2H, t, J = 7.0 Hz, j), 1.75–1.90 
(2H, m, f,i), 1.60–1.75 (2H, m, f,i), 1.45–1.60 (2H, m, g) 
13C NMR (100 MHz, CDCl3) δ 172.44 (k), 142.50 (d), 128.53 (b,b’), 128.39 (c,c’), 125.83 (a), 71.28 (h), 66.95 and 66.68 (m,m’), 46.11 and 42.14 (l,l’), 37.44 (g), 35.97 (e), 32.11 (i), 29.75 (j), 27.62 (f) 
IR (neat) 3418 (O-H stretch), 2919, 2855, 1622 (C=O stretch), 1432, 1271, 1232, 1114, 1068, 1031, 748, 699 cm-1 

























[α]D20  +7.5o (c 1.0, MeOH) 
m.p. 119.5–120.5 ºC 
TLC analysis Rf 0.3 (40:60 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralpak-IB, 70:30 hexanes:isopropanol, flow rate = 1.4 mL/min) showed peaks at 41 minutes (3.0% (R)) and 44 minutes (97.0% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.70 (1H, br s, NH), 7.51 (2H, d, J = 7.7 Hz, c,c’), 7.25–7.35 (4H, m, b,b’,m,m’), 7.15–
7.25 (3H, m, b,b’,n,n’,o), 7.12 (1H, t, J = 7.3 Hz, a), 3.60–3.80 (1H, m, h), 2.65 (2H, t, J 
= 7.8 Hz, k), 2.45–2.60 (3H, m, f, OH), 1.90–2.00 (1H, m, g), 1.70–1.85 (3H, m, g,j), 
1.50–1.60 (2H, m, i) 
13C NMR (100 MHz, CDCl3) 
δ 172.03 (e), 142.34 (l), 137.98 (d), 129.11 (b,b’), 128.53 (n,n’), 128.44 (m,m’), 125.90 
(o), 124.43 (a), 120.02 (c,c’), 71.46 (h), 37.41 (i), 35.91 (k), 34.32 (f), 32.48 (g), 27.55 
(j) 
IR (neat) 3670 (N-H stretch, O-H stretch), 3279, 3247, 2950, 2911, 1659 (C=O stretch), 1600 (N-H bend), 1543, 1496, 1412 (C-N stretch), 754, 689 cm-1 
























[α]D20  –7.9o (c 1.0, CHCl3) 
m.p. 88.5–89.5 ºC 
TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flow rate = 1.3 mL/min) showed peaks at 28 minutes (3.5% (R)) and 32 minutes (96.5% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.10–7.40 (10H, a,b,b’,c,c’,n,n’,o,o’,p), 6.28 (1H, br s, NH), 4.40 (2H, d, J = 5.7 Hz, 
e), 3.55–3.70 (1H, m, i), 3.19 (1H, d, J = 4.2 Hz, OH), 2.64 (2H, t, J = 7.6 Hz, l), 2.36 
(2H, td, J = 7.3 and 2.8 Hz, g), 1.70–1.90 (2H, m, h,k), 1.60–1.70 (2H, m, h,k), 1.40–
1.60 (2H, m, j) 
13C NMR (100 MHz, CDCl3) 
δ 173.76 (f), 142.48 (m), 138.30 (d), 128.82 (b,b’), 128.54 (o,o’), 128.42 (n,n’), 127.89 
(c,c’), 127.64 (a), 125.85 (p), 71.29 (i), 43.79 (e), 37.31 (j), 35.95 (l), 33.23 (g), 32.72 
(h), 27.61 (k) 
IR (neat) 3306 (N-H stretch, O-H stretch), 3025, 2937, 2919, 2867, 1637 (C=O stretch), 1546 (N-H bend), 1495, 1442, 1234, 724, 694 cm-1 





























[α]D20  –6.1o (c 2.0, CHCl3) 
m.p. 72.5–74.0 ºC 
TLC analysis Rf 0.35 (0:100 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralpak-IB, 60:40 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 18 minutes (94.0% (S)) and 47 minutes (6.0% (R)) 
1H NMR (400 MHz, CDCl3) 
δ 7.20–7.40 (6H, a,b,b’,c,c’,p), 6.29 (1H, dd, J = 2.9 and 2.0 Hz, o), 6.26 (1H, br s, NH, 
overlapping with o), 6.00 (1H, d, J = 3.0 Hz, n), 4.42 (2H, d, J = 5.7 Hz, e), 3.55–3.70 
(1H, m, i), 2.85–3.45 (1H, br s, OH), 2.65 (2H, t, J = 7.4 Hz, l), 2.38 (2H, td, J = 7.2 and 
3.4 Hz, g), 1.75–1.90 (2H, m, h,k), 1.60–1.75 (2H, m, h,k), 1.40–1.60 (2H, m, j) 
13C NMR (100 MHz, CDCl3) 
δ 173.72 (f), 156.17 (m), 140.86 (p), 138.28 (d), 128.83 (b,b’), 127.90 (c,c’), 127.65 (a), 
110.20 (o), 104.97 (n), 71.16 (i), 43.80 (e), 43.79 (e), 37.16 (j), 33.25 (g), 32.70 (h), 
27.98 (l), 24.33 (k) 
IR (neat) 3288 (N-H stretch, O-H stretch), 2919, 1632 (C=O stretch), 1534, 1453, 1090, 1006, 723, 695 cm-1 
























[α]D20  –4.7o (c 2.0, CHCl3) 
m.p. 73.5–74.5 ºC 
TLC analysis Rf 0.35 (0:100 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralpak-IB, 60:40 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 28 minutes (94.0% (S)) and 109 minutes (6.0% (R)) 
1H NMR (400 MHz, CDCl3) 
δ 7.35–7.40 (2H, b,b’), 7.25–7.35 (3H, a,c,c’), 7.12 (1H, dd, J = 5.1 and 1.0 Hz, p), 6.93 
(1H, dd, J = 5.0 and 3.4 Hz, o), 6.80 (1H, dd, J = 3.3 and 0.8 Hz, n), 6.16 (1H, br s, NH), 
4.43 (2H, d, J = 5.7 Hz, e), 3.60–3.70 (1H, m, i), 2.86 (2H, t, J = 7.5 Hz, l), 2.39 (2H, td, 
J = 7.2 and 3.8 Hz, g), 1.80–1.90 (2H, m, h,k), 1.65–1.80 (2H, m, h,k), 1.45–1.60 (2H, 
m, j) 
13C NMR (100 MHz, CDCl3) 
δ 173.67 (f), 145.36 (m), 138.26 (d), 128.85 (b,b’), 127.92 (c,c’), 127.68 (a), 126.82 (o), 
124.27 (n), 123.02 (p), 71.20 (i), 43.84 (e), 37.11 (j), 33.27 (g), 32.68 (h), 29.94 (l), 27.97 
(k) 
IR (neat) 3291 (N-H stretch, O-H stretch), 2917, 2849, 1630 (C=O stretch), 1534, 1453, 691 cm-1
























[α]D20  –7.1o (c 1.8, CHCl3) 
TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralpak-IC, 60:40 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 42 minutes (8.0% (R)) and 54 minutes (92.0% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.40 (5H, a,b,b’,c,c’), 6.10 (1H, br s, NH), 5.78 (2H, s, n,n’), 4.43 (2H, d, J = 5.7 
Hz, e), 3.77 (2H, t, J = 7.6 Hz, l), 3.55–3.70 (1H, m, i), 2.30–2.45 (2H, m, g), 2.24 (6H, 
s, o,o’), 1.75–1.90 (2H, m, h,k), 1.65–1.75 (2H, m, h,k), 1.45–1.55 (2H, m, j) 
13C NMR (100 MHz, CDCl3) 173.61 (f), 138.17 (d), 128.87 (b,b’), 127.92 (c,c’), 127.72 (a), 127.48 (m,m’), 105.19 (n,n’), 71.14 (i), 43.87 (e), 43.60 (l), 34.82 (j), 33.22 (g), 32.66 (h), 27.36 (k), 12.68 (o,o’)
IR (neat) 3285 (N-H stretch, O-H stretch), 2923, 1643 (C=O stretch), 1541, 1453, 1407, 1298, 742, 697 cm-1 
























[α]D20  –18.4o (c 2.0, CHCl3) 
m.p. 50.5–51.5 ºC 
TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralpak-IC, 90:10 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 96 minutes (3.0% (R)) and 103 minutes (97.0% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.40 (2H, b,b’), 7.25–7.30 (3H, a,c,c’), 6.21 (1H, br s, NH), 4.43 (2H, d, J = 5.7 
Hz, e), 3.65–3.75 (1H, m, i), 2.60–3.00 (1H, br s, OH), 2.40 (2H, td, J = 7.6 and 2.6 Hz, 
g), 1.80–1.90 (1H, m, h), 1.70–1.80 (1H, m, k), 1.60–1.70 (1H, m, h), 1.40–1.50 (1H, m, 
j), 1.20–1.25 (1H, m, j), 0.92 (6H, dd, J = 6.2 and 5.4 Hz, l,l’) 
13C NMR (100 MHz, CDCl3) δ 173.70 (f), 138.34 (d), 128.82 (b,b’), 127.89 (c,c’), 127.63 (a), 69.42 (i), 47.04 (j), 43.79 (e), 33.26 (h), 33.24 (g), 24.73 (k), 23.47 and 22.28 (l.l’) 
IR (neat) 3284 (N-H stretch, O-H stretch), 2952, 2916, 2868, 1643 (C=O stretch), 1546, 1453, 696 cm-1 
























[α]D20  –5.9o (c 2.0, CHCl3) 
m.p. 61.0–62.0 ºC 
TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralcel-OD, 60:40 hexanes:isopropanol, flowrate = 1.0 mL/min) showed peaks at 11 minutes (96.5% (S)) and 16 minutes (3.5% (R)) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, b,b’), 7.20–7.30 (a,c,c’), 6.49 (1H, br s, NH), 4.39 (2H, d, J = 5.7 Hz, 
e), 3.50–3.60 (1H, m, i), 3.26 (1H, br s, OH), 2.30–2.45 (2H, m, g), 1.80–1.90 (1H, m, 
h), 1.60–1.70 (1H, m, h), 1.50–1.60 (1H, m, l), 1.40–1.50 (2H, m, j), 1.25–1.35 (1H, m, 
k), 1.15–1.25 (1H, m, k) 0.89 (6H, dd, J = 6.6 and 1.6 Hz, m,m’) 
13C NMR (100 MHz, CDCl3) δ 173.90 (f), 138.36 (d), 128.78 (b,b’), 127.84 (c,c’), 127.57 (a), 71.72 (i), 43.72 (e), 35.60 (j), 34.97 (k), 33.23 (g), 32.75 (h), 28.20 (l), 22.76 and 22.68 (m,m’) 
IR (neat) 3452 (N-H stretch), 3294 (O-H stretch), 2951. 2931, 2901, 2868, 1615 (C=O stretch), 1545, 1454, 1249, 1063, 1029, 723, 692 cm-1 













HPLC trace of 7i 
 










[α]D20  –2.5o (c 1.0, CHCl3) 
m.p. 72.0–73.0 ºC 
TLC analysis Rf 0.5 (0:100 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.20–7.40 (5H, a,b,b’,c,c’), 6.30 (1H, br s, NH), 5.11 (1H, t, J = 5.8 Hz, p), 4.42 (2H, 
d, J = 5.5 Hz, e), 3.45–3.65 (1H, m, i), 3.05 (1H. br s, OH), 2.30–2.45 (2H, m, g), 1.80–
2.05 (3H, m, o,h), 1.70 (3H, s, r), 1.62 (3H, s, s), 1.20–1.50 (6H, m, h,j,l,n), 1.15–1.20 
(2H, m, k), 0.89 (3H, d, J = 5.5 Hz, m) 
13C NMR (100 MHz, CDCl3) 
δ 173.77 (f), 138.33 (d), 131.19 (q), 128.80 (b,b’), 127.88 (c,c’), 127.61 (a), 125.01 (p), 
71.92 (major diastereomer, 92%, i), 71.82 (minor diastereomer, 8%, i), 43.78 (e), 37.19 
(minor diastereomer, 7%, l), 37.12 (major diastereomer, 93%, l), 35.29 (n), 33.26 (g), 
32.99 (h), 32.65 (j and k overlapping), 25.83 (r), 25.64 (o), 19.67 (m), 17.77 (s) 
IR (neat) 3300 (N-H stretch, O-H stretch), 2962, 2911, 2849, 1642 (C=O stretch), 1552, 1452, 1344, 1256, 695 cm-1 














[α]D20  +6.5o (c 1.0, CHCl3) 
TLC analysis Rf 0.5 (0:100 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.30 (1H, br s, NH), 5.11 (1H, t, J 
= 6.2 Hz, p), 4.42 (2H, d, J = 5.7 Hz, e), 3.45–3.70 (1H, m, i), 3.04 (1H. br s, OH), 2.30–
2.45 (2H, m, g), 1.80–2.05 (3H, m, o,h), 1.70 (3H, s, r), 1.62 (3H, s, s), 1.20–1.50 (7H, 
m, h,j,k,l,n), 1.10–1.20 (1H, m, k), 0.89 (3H, d, J = 6.4 Hz, m) 
13C NMR (100 MHz, CDCl3) 
δ 173.77 (f), 138.33 (d), 131.19 (q), 128.80 (b,b’), 127.88 (c,c’), 127.61 (a), 125.02 (p), 
71.92 (minor diastereomer, 7%, i), 71.82 (major diastereomer, 93%, i), 43.78 (e), 37.19 
(major diastereomer, 92%, l), 37.12 (minor diastereomer, 8%, l), 35.28 (n), 33.29 (g), 
32.94 (h), 32.75 k), 32.58 (j), 25.83 (r), 25.65 (o), 19.61 (m), 17.77 (s) 
IR (neat) 3271 (N-H stretch, O-H stretch), 2912, 2851, 1651 (C=O stretch), 1616, 1538 1453, 727, 694 cm-1 














[α]D20  +7.1o (c 2.0, CHCl3) 
TLC analysis Rf 0.4 (20:80 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralpak-IC, 80:20 hexanes:isopropanol, flowrate = 1.4 mL/min) showed peaks at 29 minutes (3.0% (R)) and 35 minutes (97.0% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, b,b’), 7.25–7.30 (3H, a,c,c’), 6.28 (1H, br s, NH), 4.44 (2H, dd, J = 5.6 
and 3.2 Hz, e), 3.70–3.85 (3H, m, l, OH), 3.60–3.70 (1H, m, i),  2.42 (2H, t, J = 7.0 Hz, 
g), 1.85–1.95 (1H, m, h), 1.60–1.80 (4H, m, h,j,k), 1.50–1.60 (1H, m, j), 1.00–1.15 (3H, 
m, m,m’,m’’, overlapping with n,n’,n’’), 1.08 (18H, s, n,n’,n’’) 
13C NMR (100 MHz, CDCl3) δ 173.61 (f), 138.48 (d), 128.77 (b,b’), 127.88 (c,c’), 127.54 (a), 71.14 (i), 63.95 (l), 43.74 (e), 35.37 (j), 33.46 (g), 32.89 (h), 29.60 (k), 18.08 (n,n’,n’’), 12.02 (m,m’,m’’) 
IR (neat) 3289 (N-H stretch, O-H stretch), 2941, 2864, 1644 (C=O stretch), 1548, 1454, 1097, 881, 679 cm-1 
























[α]D20  +10.1o (c 1.0, CHCl3) 
TLC analysis Rf 0.25 (0:100 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, m, b,b’), 7.25–7.30 (3H, m, a,c,c’), 6.27 (1H, br s, NH), 4.42 (2H, d, J 
= 5.7 Hz, e), 4.05–4.15 (1H, m, l), 4.05 (1H, dd, J = 6.0 and 6.0 Hz, m), 3.60–3.70 (1H, 
m, i), 3.53 (1H, dd, J = 7.5 and 7.5 Hz, m), 3.08 (1H. br s, OH), 2.40 (2H, t, J = 6.6 Hz, 
g), 1.80–1.90 (1H, m, h), 1.60–1.80 (3H, m, h,k), 1.50–1.60 (2H, m, j), 1.41 (3H, s, o,o’), 
1.36 (3H, s, o,o’) 
13C NMR (100 MHz, CDCl3) 
δ 173.62 (f), 138.32 (d), 128.81 (b,b’), 127.87 (c,c’), 127.61 (a), 109.08 (n), 76.22 (l), 
71.17 (major diastereomer, 96%, i), 71.02 (minor diastereomer, 4%, i), 69.56 (major 
diastereomer, 96%, m), 69.54 (minor diastereomer, 4%, m), 43.78 (e), 34.19 (major 
diastereomer, 95%, j), 34.01 (minor diastereomer, 5%, j), 33.28 (g), 32.86 (h), 30.23 (k), 
27.01 (o,o’), 25.83 (o,o’) 
IR (neat) 3298 (N-H stretch, O-H stretch), 2984, 2932, 2868, 1644 (C=O stretch), 1543, 1454, 1369, 1214, 1155, 1053, 698 cm-1 














[α]D20  +22.3o (c 1.0, CHCl3) 
TLC analysis Rf 0.25 (0:100 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.44 (1H, br s, NH), 4.39 (2H, d, J 
= 5.7 Hz, e), 4.05–4.15 (1H, m, l), 4.02 (1H, dd, J = 7.6 and 7.6 Hz, m), 3.55–3.75 (2H, 
m, i, OH), 3.50 (1H, dd, J = 7.2 and 7.2 Hz, m), 2.36 (1H, t, J = 6.0 Hz, g), 1.80–1.90 
(1H, m, h), 1.55–1.80 (4H, m, h,j,k), 1.45–1.50 (1H, m, j), 1.40 (3H, s, o,o’), 1.35 (3H, 
s, o,o’) 
13C NMR (100 MHz, CDCl3) 
δ 173.68 (f), 138.28 (d), 128.75 (b,b’), 127.79 (c,c’), 127.55 (a), 108.93 (n), 76.21 (l), 
71.06 (minor diastereomer, 5%, i), 70.95 (major diastereomer, 95%, i), 69.61 (minor 
diastereomer, 5%, m), 69.51 (major diastereomer, 95%, m), 43.69 (e), 34.19 (minor 
diastereomer, 0%, j), 33.94 (major diastereomer, 100%, j), 33.18 (g), 32.73 (h), 29.79 
(k), 26.99 (o,o’), 25.79 (o,o’) 
IR (neat) 3294 (N-H stretch, O-H stretch), 2984, 2931, 2869, 1644 (C=O stretch), 1542, 1454, 1369, 1214, 1054, 698 cm-1 














[α]D20  –3.5o (c 1.0, CHCl3) 
TLC analysis Rf 0.25 (0:100 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.30–7.35 (2H, m, b,b’), 7.20–7.30 (3H, m, a,c,c’), 6.37 (1H, br s, NH), 4.40 (2H, d, J 
= 5.7 Hz, e), 4.25–4.35 (1H, m, k), 4.07 (1H, dd, J = 8.0 and 6.1 Hz, l), 3.80–3.90 (1H, 
m, i), 3.55 (1H, dd, J = 7.8 and 7.8 Hz, l), 2.39 (1H, t, J = 6.9 Hz, g), 1.80–1.90 (1H, m, 
h), 1.60–1.80 (3H, m, h,j), 1.40 (3H, s, n,n’), 1.35 (3H, s, n,n’) 
13C NMR (100 MHz, CDCl3) 
δ 173.60 (f), 138.27 (d), 128.81 (b,b’), 127.86 (c,c’), 127.62 (a), 108.81 (m), 73.79 (k), 
69.66 (major diastereomer, 92%, i), 69.49 (minor diastereomer, 8%, i), 68.58 (l), 43.77 
(e), 40.67 (minor diastereomer, 7%, j), 40.56 (major diastereomer, 93%, j), 33.15 (g), 
33.08 (h), 27.03 (n,n’), 25.78 (n,n’) 
IR (neat) 3304 (N-H stretch, O-H stretch), 2984, 2935, 2873, 1644 (C=O stretch), 1542, 1454, 1369, 1214, 1155, 1052, 698 cm-1 














[α]D20  +5.3o (c 1.44, CHCl3) 
m.p. 63.5–64.5 oC; 
TLC analysis Rf 0.4 (0:100 hexanes:ethyl acetate) 
1H NMR (300 MHz, CDCl3) 
δ 7.20–7.40 (5H, a,b,b’,c,c’), 6.48 (1H, br s, NH), 4.40 (2H, d, J = 5.2 Hz, e), 3.40–3.60 
(1H, m, i), 3.21 (1H, br s, OH), 2.37 (2H, t, J = 6.5 Hz, g) 1.75–1.95 (1H, m, h), 1.55–
1.75 (1H, m, h), 1.40–1.55 (2H, m, j), 0.93 (3H, t, J = 7.2 Hz, k) 
13C NMR (75 MHz, CDCl3) δ 173.80 (f), 138.24 (d), 128.67 (b,b’), 127.74 (c,c’), 127.46 (a), 72.67 (i), 43.62 (e), 33.12 (g), 32.16 (h), 30.40 (j), 10.02 (k) 
IR (neat) 3280 (N-H stretch, O-H stretch), 2964, 2920, 2877, 1631 (C=O stretch), 1549 (N-H bend), 1493, 1326, 1264, 936, 729, 693 cm-1 














[α]D20  –34.5o (c 1.87, CHCl3) 
TLC analysis Rf 0.5 (50:50 hexanes:ethyl acetate) 
19F NMR (376 MHz, CDCl3) δ –71.01 (s, 5%, minor, CF3), –71.08 (s, 95%, major, CF3) 
1H NMR (400 MHz, CDCl3) 
δ 7.50–7.60 (2H, m, r,r’), 7.25–7.45 (8H, a,b,b’,c,c’,q,q’,s), 5.74 (0.94H, br s, major NH), 
5.52 (0.05H, br s, minor NH), 5.00–5.15 (1H, m, i),  4.44 (2H, d, J = 5.7 Hz, e), 3.54 
(3H, s, n), 2.05–2.30 (3H, m, g,h), 1.95–2.05 (1H, m, h), 1.60–1.70 (2H, m, j), 0.96 
(0.12H, t, J = 7.4 Hz, minor k), 0.86 (2.89H, t, J = 7.4 Hz, major k) 
13C NMR (100 MHz, CDCl3) 
δ 171.60 (f), 166.59 (l), 138.26 (d), 132.26 (p), 129.74 (r,r’), 128.85 (b,b’), 128.57 (q,q’), 
127.98 (c,c’), 127.70 (s), 127.54 (a), 123.50 (q, J = 287 Hz, o), 84.79 and 84.52 (m), 
78.16 (i), 55.47 (n), 43.82 (e), 32.21 (g), 29.38 (h), 26.82 (j), 9.37 (k) 
IR (neat) 3293 (N-H stretch), 2970, 2935, 1741 (C=O stretch), 1644 (C=O stretch), 1545 (N-H bend), 1452, 1258, 1165, 1121, 1016, 992, 715, 696 cm-1 






















[α]D20  +0.5o (c 1.0, CHCl3) 
m.p. 61.5–62.5 ºC 
19F NMR (376 MHz, CDCl3) δ –133.36 (s, BF3Cs) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.30 (2H, m, b,b’), 7.15–7.20 (3H, m, a,c,c’), 3.55–3.60 (4H, m, m,m’), 3.45–
3.55 (2H, m, l,l’), 3.30–3.40 (2H, m, l,l’), 2.58 (2H, t, J = 6.9 Hz, e), 2.25–2.35 (1H, m, 
j), 2.15–2.25 (1H, m, j), 1.50–1.70 (3H, m, f,i), 1.30–1.45 (2H, m, g,i), 1.10–1.25 (1H, 
m, g), 0.25–0.40 (1H, m, h) 
13C NMR (100 MHz, CDCl3) δ 173.90 (k), 143.63 (d), 128.68 (b,b’), 128.39 (c,c’), 125.64 (a), 66.94 and 66.86 (m,m’), 46.28 and 41.86 (l,l’), 36.70 (e), 31.79 (j), 31.07 (f), 30.09 (g), 26.60 (i) 
IR (neat) 2908, 2854, 1609 (C=O stretch), 1461 (N-H bend), 1434, 1240 (C-N stretch), 1114, 1064, 957, 932, 742, 702 cm-1 



















[α]D20  –2.9o (c 1.0, MeOH) 
m.p. 57.5–58.5 ºC 
19F NMR (376 MHz, MeOD) δ –131.52 (s, BF3Cs) 
1H NMR (400 MHz, MeOD) 
δ 7.00–7.40 (10H, m, a,b,b’,c,c’,n,n’,o,o’,p), 4.36 (2H, s, l), 2.56 (2H, t, J = 7.7 Hz, e), 
2.30 (2H, t, J = 8.1 Hz, j), 1.55–1.80 (4H, m, f,i), 1.40–1.55 (1H, m, g), 1.20–1.30 (1H, 
m, g), 0.30–0.50 (1H, m, h) 
13C NMR (100 MHz, MeOD) 
δ 177.08 (k), 143.66 (d), 138.97 (m), 128.16 (b,b’), 128.14 (o,o’), 127.76 (n,n’), 127.16 
(c,c’), 126.74 (p), 124.94 (a), 42.67 (l), 36.67 (e), 36.01 (j), 31.06 (f), 30.79 (g), 27.83 
(i) 
IR (neat) 3408 (N-H stretch), 3294 2919, 2852, 1640 (C=O stretch), 1521, 1495, 1452 (N-H bend), 1528, 912, 744, 697 cm-1 


















[α]D20  –3.7o (c 1.0, CHCl3) 
TLC analysis Rf = 0.4 (80:20 DCM:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralpak-IC, 80:20 hexanes:isopropanol, flowrate = 1.5 mL/min) showed peaks at 75 minutes (6.5% (R)) and 81 minutes (93.5% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.05–7.35 (10H, m, a,b,b’,c,c’,o,o’,p,p’,q), 3.50–3.65 (6H, m, l,l’,m,m’), 3.10–3.30 
(2H, m, l,l’), 2.50–2.65 (3H, m, e,h), 2.05–2.15 (3H, m, i,j), 1.80–1.90 (1H, m, i), 1.60–
1.75 (2H, m, g), 1.45–1.60 (2H, m, f) 
13C NMR (100 MHz, CDCl3) 
δ 171.72 (k), 144.84 (d), 142.55 (n), 128.60 (b,b’), 128.49 (p,p’), 128.33 (c,c’), 127.79 
(o,o’), 126.42 (a), 125.74 (q), 67.01 and 66.67 (m,m’), 45.88 (l,l’), 45.61 (h), 41.95 (l,l’), 
36.76 (g), 36.00 (e), 32.08 (i), 30.97 (j), 29.42 (f) 
IR (neat) 2919, 2851, 1644 (C=O stretch), 1452, 1426, 1230, 1114, 1029, 747, 699 cm-1 





























[α]D20  –7.1o (c 2.0, CHCl3) 
TLC analysis Rf = 0.4 (80:20 DCM:ethyl acetate) 
HPLC analysis Chiral HPLC analysis ((S,S)-WHELK-O 1, 50:50 hexanes:isopropanol, flow rate = 1.0 mL/min showed peaks at 25 minutes (6.0% (R)) and 28 minutes (94.0% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.26 (2H, t, J = 7.2 Hz, o,o’), 7.17 (1H, t, J = 7.3 Hz, a), 7.11 (2H, d, J = 7.1 Hz, c,c’), 
7.06 (2H, d, J = 8.6 Hz, b,b’), 6.85 (2H, d, J = 8.6 Hz, p,p’), 3.81 (3H, s, r), 3.60–3.65 
(2H, m, m,m’), 3.55–3.60 (4H, m, l,l’,m,m’), 3.15–3.30 (2H, m, l,l’), 2.45–2.65 (3H, m, 
e,h), 2.00–2.15 (3H, m, i,j), 1.75–1.85 (1H, m, i), 1.45–1.75 (4H, m, f,g) 
13C NMR (100 MHz, CDCl3) 
δ 171.80 (k), 158.12 (q), 142.60 (d), 136.77 (n), 128.61 (b,b’), 128.49 (c,c’), 128.32 
(o,o’), 125.72 (a), 113.96 (p,p’), 67.02 and 66.69 (m,m’), 55.34 (r), 45.90 (l,l’), 44.76 
(h), 41.95 (l,l’), 36.93 (g), 36.01 (e), 32.25 (i), 31.02 (j), 29.44 (f) 
IR (neat) 2920, 2852, 1643 (C=O stretch), 1510, 1426, 1244, 1113, 1030, 831, 700 cm-1 

























[α]D20  +121o (c 1.0, CHCl3) 
m.p. 143.5–144.5 ºC 
TLC analysis Rf = 0.4 (70:30 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.49 (2H, d, J = 7.3 Hz), 7.25–7.45 (10H, m), 7.15–7.25 (3H, m), 6.54 (1H, d, J = 15.8 
Hz), 6.20–6.30 (1H, m), 5.33 (1H, dd, J = 9.0 and 6.2 Hz), 4.60–4.70 (1H, m), 4.00–4.20 
(2H, m), 3.32 (1H, dd, J = 13.4 and 3.1 Hz), 3.05–3.20 (1H, m), 2.70–2.80 (2H, m) 
13C NMR (100 MHz, CDCl3) δ 173.64, 153.11, 138.36, 137.42, 135.34, 132.76, 129.54, 129.05, 128.84, 128.77, 128.65, 127.67, 127.44, 127.38, 127.01, 126.26, 65.88, 55.80, 48.87, 38.02, 37.96 
IR (neat) 3029, 1762 (C=O stretch), 1691 (C=O stretch), 1494, 1392, 1369, 1349, 1243, 1224, 1210, 1185, 1109, 1053, 984, 969, 743, 716, 700, 690 cm-1 

























[α]D20  –22.1o (c 1.04, CHCl3) 
TLC analysis Rf 0.5 (75:25 hexanes:ethyl acetate) 
1H NMR (400 MHz, CDCl3) δ 7.25–7.35 (2H, b,b’), 7.15–7.25 (2H, a,c,c’), 4.45–4.60 (1H, m, h), 2.69 (2H, t, J = 6.9 Hz, e), 2.54 (2H, dd, J = 9.4 and 7.0 Hz, j), 2.25–2.40 (1H, m, i), 1.65–1.90 (5H, m, f,g,i)














[α]D20  –9.1o (c 2.0, CHCl3) 
TLC analysis Rf = 0.4 (80:20 DCM:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralcel-OJ-H, 100% isopropanol, flow rate = 1.0 mL/min) showed peaks at 12 minutes (5.5% (R)) and 18 minutes (94.5% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.30 (2H, m, c,c’), 7.10–7.20 (4H, m, a,b,b’,r), 6.94 (1H, dd, J = 4.9 and 3.5 Hz, 
q), 6.79 (1H, d, J = 3.0, p), 3.55–3.70 (6H, m, l,l’,m,m’), 3.25–3.35 (2H, m, l,l’), 2.90–
3.00 (1H, m, h), 2.55–2.65 (2H, m, e), 2.10–2.25 (3H, m, i,j), 1.55–1.85 (5H, m, f,g,i) 
13C NMR (100 MHz, CDCl3) 
δ 171.51 (k), 149.02 (o), 142.43 (d), 128.50 (b,b’), 128.37 ( c,c’), 126.65 (q), 125.79 (a), 
124.28 (p), 123.18 (r), 67.02 and 66.71 (m,m’), 45.92 and 41.99 (l,l’), 40.93 (h), 37.89 
(g), 35.86 (e), 33.24 (i), 30.78 (j), 29.28 (f) 
IR (neat) 2920, 2853, 1642 (C=O stretch), 1452, 1429, 1229, 1113, 697 cm-1 
























[α]D20  +7.5o (c 1.5, CHCl3) 
TLC analysis Rf 0.2 (5:95 methanol:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralcel-OJ-H, 90:10 hexanes:isopropanol, flow rate = 1.5 mL/min) showed peaks at 18 minutes (94.0% (S)) and 20 minutes (6.0% (R)) 
1H NMR (400 MHz, CDCl3) 
δ 7.25–7.35 (7H, m, c,c’,p,p’,q,q’,r), 7.15–7.25 (3H, a,b,b’), 3.70–3.80 (2H, m, n), 3.55–
3.70 (6H, m, l,l’,m,m’), 3.35–3.50 (2H, m, l,l’), 2.60–2.70 (3H, m, e,h), 2.36 (2H, t, J = 
7.5 Hz, j), 1.80–1.90 (1H, m, i), 1.60–1.80 (1H, m, f,i), 1.45–1.60 (2H, m, g) 
13C NMR (100 MHz, CDCl3) 
δ 172.10 (k), 142.40 (d), 140.76 (o), 128.55 (b,b’), 128.51 (q,q’), 128.43 (c,c’), 128.28 
(p,p’), 127.06 (r), 125.89 (a), 67.04 and 66.76 (m,m’), 56.17 (h), 50.99 (n), 46.03 and 
42.03 (l,l’), 36.07 (e), 33.47 (g), 29.02 (j), 28.99 (i), 27.64 (f) 
IR (neat) 2934, 2854, 1640 (C=O stretch), 1452, 1430, 1114, 746, 698 cm-1 
























[α]D20  +30.5o (c 0.74, CHCl3) 
TLC analysis Rf 0.4 (40:60 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis ((S,S)-WHELK-O 1, 100% isopropanol, flow rate = 1.0 mL/min) showed peaks at 9 minutes (5.5% (R)) and 17 minutes (94.5% (S)) 
1H NMR (400 MHz, CDCl3) 
δ 7.35–7.45 (4H, m, m,m’,n,n’), 7.20–7.30 (4H, m, a,b,b’,o), 7.12 (2H, d, J = 7.2 Hz, 
c.c’), 4.30–4.30 (1H, m, h), 2.50–2.70 (4H, m, e,j), 2.30–2.40 (1H, m, i), 1.80–1.90 (1H, 
m, i), 1.55–1.80 (3H, m, f,g), 1.40–1.50 (1H, m, g) 
13C NMR (100 MHz, CDCl3) 
δ 174.46 (k), 141.83 (d), 137.71 (l), 129.15 (n,n’), 128.50 (b,b’), 128.36 (c,c’), 126.06 
(o), 126.00 (a), 124.32 (m,m’), 59.78 (h), 35.71 (e), 33.08 (g), 31.41 (j), 26.50 (f), 24.07 
(i) 
IR (neat) 2933, 1690 (C=O stretch), 1596, 1496, 1388, 1292, 1220, 752, 693 cm-1 

























[α]D20  +20.4o (c 2.0, CHCl3) 
m.p. 48.5–49.0 ºC 
TLC analysis 0.2 (5:95 methanol:ethyl acetate) 
1H NMR (400 MHz, CDCl3) 
δ 7.20–7.40 (10H, a,b,b’,c,c’,n,n’,o,o’,p), 3.80 (2H, d, J = 1.9 Hz, e), 3.40–3.70 (2H, m, 
i,OH), 2.75–2.85 (1H, m, f), 2.67 (2H, t, J = 7.7 Hz, l), 2.55–2.65 (1H, m, f), 1.65–1.90 
(4H, m, h,k), 1.40–1.60 (4H, m, g,j) 
13C NMR (100 MHz, CDCl3) 
δ 142.85 (m), 139.41 (d), 128.69 (b,b’), 128.58 (o,o’), 128.45 (n,n’), 127.35 (c,c’), 
127.37 (a), 125.72 (p), 71.33 (i), 53.98 (e), 49.57 (f), 37.51 (j), 37.19 (h), 36.20 (l), 27.97 
(k), 27.41 (g) 
IR (neat) 3267 (N-H stretch, O-H stretch), 3084, 3026, 2868, 2827, 2813, 1495, 1451, 1363 (C-N stretch), 1346, 1118, 858, 734, 691 cm-1 














[α]D20  –4.1o (c 2.0, CHCl3) 
TLC analysis Rf 0.5 (50:50 hexanes:ethyl acetate) 
HPLC analysis Chiral HPLC analysis (Chiralcel-OJ-H, 90:10 hexanes:isopropanol, flow rate = 1.0 mL/min) showed peaks at 18 minutes (4.0% (R)) and 22 minutes (96.0% (S)) 
1H NMR (400 MHz, CDCl3) 
7.35–7.40 (2H, m, b,b’), 7.25–7.35 (5H, a, n,n’,o,o’), 7.15–7.25 (3H. c,c’,p), 5.76 (1H, 
br s, NH), 5.50 (1H, dt, J = 17.0 and 9.6 Hz, q), 5.02 (1H, dd, J = 10.1 and 1.6 Hz, r), 
4.96 (1H, dd, J = 17.1 and 1.5 Hz, r), 4.45 (2H, dd, J = 5.1 and 4.0 Hz, e), 2.50–2.70 
(2H, m, l), 2.20–2.30 (1H, m, g), 2.10–2.20 (1H, m, g), 1.95–2.10 (1H, m, i), 1.80–1.90 
(1H, m, k), 1.50–1.75 (3H, m, h,k), 1.40–1.50 (1H, m, j), 1.30–1.40 (1H, m, j) 
13C NMR (100 MHz, CDCl3) 
δ 172.96 (f), 142.72 (q), 142.36 (m), 138.54 (d), 128.83 (o,o’), 128.53 (b,b’), 128.38 
(n,n’), 127.98 (c,c’) 127.63 (a), 125.76 (p), 115.58 (r), 43.96 (i), 43.71 (e), 36.03 (l), 
34.77 (j), 34.59 (g), 30.69 (k), 29.13 (h) 
IR (neat) 3275 (N-H stretch), 3063, 3027, 2925, 2856, 1641 (C=O stretch), 1541, 1495, 1453, 911, 745, 696 cm-1 
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